<SEC-DOCUMENT>0001213900-23-014884.txt : 20230227
<SEC-HEADER>0001213900-23-014884.hdr.sgml : 20230227
<ACCEPTANCE-DATETIME>20230227170539
ACCESSION NUMBER:		0001213900-23-014884
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230223
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230227
DATE AS OF CHANGE:		20230227

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORAMED PHARMACEUTICALS INC.
		CENTRAL INDEX KEY:			0001176309
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				980376008
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35813
		FILM NUMBER:		23676393

	BUSINESS ADDRESS:	
		STREET 1:		1185 AVENUE OF THE AMERICAS, 3RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036
		BUSINESS PHONE:		646-844-1164

	MAIL ADDRESS:	
		STREET 1:		1185 AVENUE OF THE AMERICAS, 3RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Integrated Security Technologies, Inc.
		DATE OF NAME CHANGE:	20040614

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IGUANA VENTURES LTD
		DATE OF NAME CHANGE:	20020625
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea174308-8k_oramed.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:ORMP="http://oramed.com/20230223">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_03E_ORMP_oramed.com_20230223 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20230223_20230223 -->
<!-- Field: Set; Name: xdx; ID: xdx_052_edei%2D%2DEntityCentralIndexKey_0001176309 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-02-23to2023-02-23" name="dei:EntityCentralIndexKey">0001176309</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-02-23to2023-02-23" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-02-23to2023-02-23" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ormp-20230223.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-02-23to2023-02-23">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-23</xbrli:startDate>
        <xbrli:endDate>2023-02-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_907_edei--DocumentType_c20230223__20230223_za2USonj5i4g"><ix:nonNumeric contextRef="From2023-02-23to2023-02-23" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of report (Date of earliest event reported):
<b><span id="xdx_903_edei--DocumentPeriodEndDate_c20230223__20230223_zcqIwGNoeTCb"><ix:nonNumeric contextRef="From2023-02-23to2023-02-23" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">February 23, 2023</ix:nonNumeric></span> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityRegistrantName_c20230223__20230223_zgGH1EM5BnL6"><ix:nonNumeric contextRef="From2023-02-23to2023-02-23" name="dei:EntityRegistrantName">ORAMED PHARMACEUTICALS INC.</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact name of registrant as specified in its charter)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--EntityIncorporationStateCountryCode_c20230223__20230223_zKNlxXyYEDR9" style="text-transform: uppercase"><ix:nonNumeric contextRef="From2023-02-23to2023-02-23" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--EntityFileNumber_c20230223__20230223_zWaRObOKHOR9"><ix:nonNumeric contextRef="From2023-02-23to2023-02-23" name="dei:EntityFileNumber">001-35813</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityTaxIdentificationNumber_c20230223__20230223_z5BuCWA4Qcqc"><ix:nonNumeric contextRef="From2023-02-23to2023-02-23" name="dei:EntityTaxIdentificationNumber">98-0376008</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or Other Jurisdiction</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File Number)</span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS Employer</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of Incorporation)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--EntityAddressAddressLine1_c20230223__20230223_zMyeV5qbSvK5"><ix:nonNumeric contextRef="From2023-02-23to2023-02-23" name="dei:EntityAddressAddressLine1">1185 Avenue of the Americas</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressAddressLine2_c20230223__20230223_zHtPJCIuMHl3"><ix:nonNumeric contextRef="From2023-02-23to2023-02-23" name="dei:EntityAddressAddressLine2">Third Floor</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressCityOrTown_c20230223__20230223_zHyZPipjtkKg"><ix:nonNumeric contextRef="From2023-02-23to2023-02-23" name="dei:EntityAddressCityOrTown">New York</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressStateOrProvince_c20230223__20230223_zlIAMjnNNa21"><ix:nonNumeric contextRef="From2023-02-23to2023-02-23" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityAddressPostalZipCode_c20230223__20230223_zuOCMOhCbo2"><ix:nonNumeric contextRef="From2023-02-23to2023-02-23" name="dei:EntityAddressPostalZipCode">10036</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address of Principal Executive Offices)</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_909_edei--CityAreaCode_c20230223__20230223_zo1cRMhA6Om6"><ix:nonNumeric contextRef="From2023-02-23to2023-02-23" name="dei:CityAreaCode">844</ix:nonNumeric></span>-<span id="xdx_903_edei--LocalPhoneNumber_c20230223__20230223_zuH7H4aZPnWf"><ix:nonNumeric contextRef="From2023-02-23to2023-02-23" name="dei:LocalPhoneNumber">967-2633</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span id="xdx_908_edei--WrittenCommunications_c20230223__20230223_zcvSDdsoX82c"><ix:nonNumeric contextRef="From2023-02-23to2023-02-23" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></td><td style="text-align: justify">Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span id="xdx_90F_edei--SolicitingMaterial_c20230223__20230223_zuhUu6xhIXL6"><ix:nonNumeric contextRef="From2023-02-23to2023-02-23" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></td><td style="text-align: justify">Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span id="xdx_90E_edei--PreCommencementTenderOffer_c20230223__20230223_zyGFRQ0rCUuc"><ix:nonNumeric contextRef="From2023-02-23to2023-02-23" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span id="xdx_907_edei--PreCommencementIssuerTenderOffer_c20230223__20230223_z2WMoa8ENAta"><ix:nonNumeric contextRef="From2023-02-23to2023-02-23" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Securities registered pursuant to Section
12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of each class</span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading symbol</span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--Security12bTitle_c20230223__20230223_zm7ULqE9m0G3"><ix:nonNumeric contextRef="From2023-02-23to2023-02-23" name="dei:Security12bTitle">Common Stock, par value $0.012</ix:nonNumeric></span></b></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--TradingSymbol_c20230223__20230223_zz844NyPAxMh"><ix:nonNumeric contextRef="From2023-02-23to2023-02-23" name="dei:TradingSymbol">ORMP</ix:nonNumeric></span></b></span></td>
    <td>&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>The <span id="xdx_902_edei--SecurityExchangeName_c20230223__20230223_zGqg7C0me3J9"><ix:nonNumeric contextRef="From2023-02-23to2023-02-23" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market, </b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Tel Aviv Stock Exchange</b></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Indicate by check mark whether
the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule
12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Emerging growth company <span id="xdx_909_edei--EntityEmergingGrowthCompany_c20230223__20230223_z0mJlebY50Sg"><ix:nonNumeric contextRef="From2023-02-23to2023-02-23" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 5.03 Amendments to Articles of Incorporation
or Bylaws; Change in Fiscal Year.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 23, 2023, the
board of directors of Oramed Pharmaceuticals Inc. (the &#8220;Company&#8221;) adopted Fourth Amended and Restated By-laws (the &#8220;By-laws&#8221;),
which became effective immediately, to among other things, (i) implement rules for stockholder action by written consent, including procedures
for a record date to be set by the board of directors of the Company in connection with such action, information requirements, the engagement
of an independent inspector of election and timing requirements, (ii) eliminate outdated or unnecessary provisions that are governed by
the Delaware General Corporation Law, (iii) limit the Company&#8217;s required indemnification of a person party to or threatened to be
made a party to any proceeding commenced by such person only if the commencement of such proceeding was authorized by the Board, (iv)
reduce any obligation to indemnify or advance expenses to a person serving at the Company&#8217;s request as a director or officer of
another entity by any amount such person may collect as indemnification or advancement of expenses from such other entity and (v) with
respect to the ability of the stockholders of the Company to alter, amend or repeal the By-laws or adopt new by-laws of the Company, require
the affirmative vote of the holders of a majority in voting power of the outstanding shares of capital stock of the Company entitled to
vote thereon.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">The
foregoing description of the By-laws is qualified in its entirety by reference to the full text of the By-laws, a copy of which is filed
as Exhibit 3.1 to this Current Report on Form 8-K and which is incorporated herein by reference. In addition, a marked copy of the By-laws
indicating the changes made to such document is filed as Exhibit 3.2 to this Current Report on Form 8-K, which is incorporated herein
by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9.01 Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(d) Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 9%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 90%; text-align: justify"><a href="ea174308ex3-1_oramed.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fourth Amended
and Restated By-laws, adopted effective February 23, 2023. (Filed herewith).</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea174308ex3-2_oramed.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Fourth
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated By-laws, adopted effective February
23, 2023 (marked copy). (Filed herewith).</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ORAMED PHARMACEUTICALS INC.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Nadav Kidron</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nadav Kidron</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and CEO</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">February 27, 2023</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">2</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KgkAQhZ/Adxj2Okw3JPCupCKyCJHodssplnRHZre/R+otW5VoGBiGc75zhBiJFS11jQzHeZFDiU1bK4dQ4AUZzRm9I1tvUvC3wKu2jpVx/fsDM/IMeiYJ4+nJC731oS1WKURyLKdjOYEoSWMJs60IOj0jc9EVGqdVDcpUsGdqWaNT/B4SSvUiQ827rzogW00mhTiMBvkDMvJ5O3qoJ/HNQp5nIhj1E4gV073tau7WUQOLGhvfZQf0v8EXEj9JPg== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ea174308ex3-1_oramed.htm
<DESCRIPTION>FOURTH AMENDED AND RESTATED BY-LAWS, ADOPTED EFFECTIVE FEBRUARY 23, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.9pt 0pt 5pt; text-align: right; text-indent: 0.55pt">Exhibit 3.1</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.9pt 0pt 5pt; text-align: right; text-indent: 0.55pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.9pt 0pt 5pt; text-align: center; text-indent: 0.55pt">ORAMED PHARMACEUTICALS
INC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.9pt 0pt 5pt; text-align: center; text-indent: 0.55pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.9pt 0pt 5pt; text-align: center; text-indent: 0.55pt">FOURTH AMENDED
AND RESTATED BY-LAWS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.9pt 0pt 5pt; text-align: center; text-indent: 0.55pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 2pt 0pt 0; text-align: center; text-indent: 0.55pt">ARTICLE I</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">OFFICES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">1.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The location of the registered office of the Corporation, and the name of its registered agent, shall be as set forth in the Certificate
of Incorporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Corporation shall in addition to its registered office in the State of Delaware establish and maintain an office or offices
at such place or places as the Board of Directors may from time to time find necessary or desirable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0.55pt">ARTICLE II</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">CORPORATE SEAL</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt">The Corporation may or may not have a corporate seal, as
may be determined from time to time by the Board of Directors. If adopted, the corporate seal of the Corporation shall have inscribed
thereon the name of the Corporation and may be in such form as the Board of Directors may determine. Such seal may be used by causing
it or a facsimile thereof to be impressed, affixed or otherwise reproduced.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0.55pt">ARTICLE III</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">MEETINGS OF STOCKHOLDERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">1.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>All meetings of the stockholders shall be held at the registered office of the Corporation in the State of Delaware or at such
other place, as shall be determined from time to time by the Board of Directors. The Board of Directors may, in its sole discretion, determine
that any meeting of the stockholders shall not be held at any place, but may instead be held solely by means of remote communication in
accordance with Section 211 of the General Corporation Law of the State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The annual meeting of stockholders shall be held on such day and at such time as may be determined from time to time by resolution
of the Board of Directors, when they shall elect, by majority vote pursuant to Section 5 of this Article III, directors to hold office
until the annual meeting of stockholders held next after their election and their successors are respectively elected and qualified, or
until their earlier death, disqualification, resignation or removal. Any other proper business may be transacted at the annual meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">3.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The holders of at least one third (1/3) of the stock issued and outstanding and entitled to vote on the subject matter, present
in person or represented by proxy, shall constitute a quorum at all meetings of the stockholders for the transaction of business, except
as otherwise expressly provided by statute, by the Certificate of Incorporation or by these By-laws. If, however, such holders shall not
be present or represented at any meeting of the stockholders, the stockholders entitled to vote on the subject matter, present in person
or by proxy, shall have power to adjourn the meeting from time to time, without notice other than announcement at the meeting (except
as otherwise provided by statute). At such adjourned meeting at which a quorum is present, any business may be transacted which might
have been transacted at the meeting as originally notified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">4.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>At all meetings of the stockholders each stockholder having the right to vote on the subject matter shall be entitled to vote in
person, or by proxy, but no proxy shall be voted or acted upon more than three years after its date, unless the proxy provides for a longer
period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">5. Unless otherwise provided in the
Certificate of Incorporation, at each meeting of the stockholders each stockholder shall have one vote for each share of capital
stock having voting power, registered in his or her name on the books of the Corporation at the record date fixed for voting in
accordance with these By-laws, or otherwise determined, with respect to such meeting. Unless a different or minimum vote is required
by law or regulation applicable to the Corporation or its securities, by the Certificate of Incorporation, by these By-laws or by
the rules or regulations of any stock exchange applicable to the Corporation, in which case such different or minimum vote shall be
the applicable vote on the matter, all matters coming before any meeting of the stockholders, including the election of directors,
shall be decided by a majority of the votes cast by the holders of shares of stock present in person or represented by proxy at such
meeting and entitled to vote on the subject matter, a quorum being present. Votes cast shall include votes &ldquo;for&rdquo; and
votes &ldquo;against&rdquo; and exclude &ldquo;abstentions&rdquo; and &ldquo;broker non-votes&rdquo; with respect to the subject
matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">6.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Notice of each meeting of the stockholders shall be given to each stockholder entitled to vote thereat not less than ten (10) nor
more than sixty (60) days before the date of the meeting. Such notice shall state the place, date and hour of meeting, the record date
for determining the stockholders entitled to vote at the meeting, if such date is different from the record date for determining stockholders
entitled to notice of the meeting, the means of remote communications, if any, by which stockholders and proxy holders may be deemed to
be present in person and vote at such meeting and, in the case of a special meeting, the purpose or purposes for which the meeting is
called.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">7.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Corporation shall prepare, no later than the tenth (10th) day before each meeting of stockholders, a complete list of the stockholders
entitled to vote at said meeting (provided, however, if the record date for determining the stockholders entitled to vote is less than
ten (10) days before the date of the meeting, the list shall reflect the stockholders entitled to vote as of the tenth day before the
meeting date), arranged in alphabetical order, showing the address of each stockholder and the number of shares registered in the name
of each stockholder. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting for a period
of 10 days ending on the day before the meeting date, (a) on a reasonably accessible electronic network, provided that the information
required to gain access to such list is provided with the notice of the meeting, or (b) during ordinary business hours, at the principal
place of business of the Corporation. In the event that the Corporation determines to make the list available on an electronic network,
the Corporation may take reasonable steps to ensure that such information is available only to stockholders of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">8.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Special meetings of the stockholders, for any purpose or purposes, unless otherwise prescribed by statute, may be called by the
majority of the Board of Directors, but such meetings may not be called by any other person or persons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">9.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Only such business shall be conducted at a special meeting of stockholders as shall have been brought before the meeting pursuant
to the Corporation&rsquo;s notice of meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">10.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The order of business at each meeting of stockholders shall be determined by the person presiding over the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">11. (a) In order that the
Corporation may determine the stockholders entitled to consent to corporate action by consent and without a meeting of stockholders,
the Board of Directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the
record date is adopted by the Board of Directors, and which date shall not be more than ten (10) days after the date upon which the
resolution fixing the record date is adopted by the Board of Directors. Any stockholder of record seeking to have the stockholders
authorize or take corporate action by consent in lieu of a meeting of stockholders shall, by written notice delivered to the
Secretary of the Corporation at the principal executive offices of the Corporation, request that the Board of Directors fix a record
date. The written notice must contain the information set forth in Section 11(b) of this Article III. The Board of Directors shall
promptly, but in all events within ten (10) days after the date on which such written notice is received by the Secretary of the
Corporation, determine the validity of the request, and if appropriate, adopt a resolution fixing the record date (unless a record
date has previously been fixed by the Board of Directors pursuant to the first sentence of this Section 11(a) of Article III). If no
record date has been fixed by the Board of Directors pursuant to the first sentence of this Section 11(a) of Article III or
otherwise within ten (10) days after the date on which such written notice is received by the Secretary of the Corporation, the
record date for determining stockholders entitled to consent to corporate action by consent and without a meeting, when no prior
action by the Board of Directors is required by applicable law, shall be the first date after the expiration of such ten (10) day
time period on which a signed consent setting forth the action taken or proposed to be taken is delivered to the Corporation by
delivery to its registered office in Delaware by hand or by certified or registered mail, return receipt requested, to its principal
place of business or to any officer or agent of the Corporation having custody of the book in which proceedings of meetings of
stockholders are recorded. If no record date has been fixed by the Board of Directors pursuant to the first sentence of this Section
11(a) of Article III and prior action by the Board of Directors is required by applicable law, the record date for determining
stockholders entitled to consent to corporate action by consent and without a meeting shall be at the close of business on the date
on which the Board of Directors adopts the resolution taking such prior action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 85.05pt">(b)    Any
stockholder&rsquo;s notice required by Section 11(a) of Article III must describe the action that the stockholder proposes to take by
consent. For each such proposal, every notice by a stockholder must state (x) the information required by Section 2 of Article IV and
Section 2 of Article V as though such stockholder was intending to make a nomination or to bring any such business before a meeting of
stockholders and (y) the text of the proposal (including the text of any resolutions to be effected by consent and the language of any
proposed amendment to these By-Laws). In addition to the foregoing, the notice must state as to the stockholder giving the notice and
the beneficial owner, if any, on whose behalf the notice is given a representation whether the stockholder or the beneficial owner, if
any, intends or is part of a group which intends to (x) deliver a proxy statement and/or consent solicitation statement to stockholders
of at least the percentage of the Corporation&rsquo;s outstanding capital stock required to effect the action by consent either to solicit
consents or to solicit proxies to execute consents, and/or (y) otherwise solicit proxies or consents from stockholders in support of the
action to be taken by consent. The Corporation may require the stockholder of record and/or beneficial owner requesting a record date
for proposed stockholder action by consent to furnish such other information as it may reasonably require to determine the validity of
the request for a record date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 85.05pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 85.5pt">(c)    In
the event of the delivery, in the manner provided by this Section 11 of Article III and applicable law, to the Corporation of consent
or consents to take corporate action and/or any related revocation or revocations, the Corporation shall engage independent inspectors
of elections for the purpose of performing promptly a ministerial review of the validity of the consents and any consent revocations.
For the purpose of permitting the inspectors to perform such review, no stockholder action by consent and without a meeting shall be effective
until such inspectors have completed their review, determined that the requisite number of valid and unrevoked consents delivered to the
Corporation in accordance with this Section 11 of Article III and applicable law have been obtained to authorize or take the action specified
in the consents, and certified such determination for entry in the records of the Corporation kept for the purpose of recording the proceedings
of meetings of stockholders. Nothing contained in this Section 11(c) of Article III shall in any way be construed to suggest or imply
that the Board of Directors or any stockholder shall not be entitled to contest the validity of any consent or revocation thereof, whether
before or after such certification by the independent inspectors, or to take any other action (including, without limitation, the commencement,
prosecution or defense of any litigation with respect thereto, and the seeking of injunctive relief in such litigation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 85.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 85.5pt">(d)    No
stockholder consent to corporate action without a meeting of stockholders shall be effective to take the corporate action referred to
therein unless, within sixty (60) days after the first date a consent is delivered in accordance with this Section 11 of Article III,
a valid consent or valid consents signed by a sufficient number of stockholders to take such action are delivered to the Corporation in
the manner prescribed in this Section 11 of Article III and applicable law, and not revoked.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 85.5pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">ARTICLE IV</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">STOCKHOLDER PROPOSALS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">1. At an annual meeting of stockholders, only
such stockholder business shall be conducted as shall have been properly brought before the meeting. To be properly brought before
an annual meeting of stockholders, stockholder business (other than the nominations of persons for election to the Board of
Directors, which shall be set forth in Article V) must be: (i) specified in the notice of the meeting (or any supplement thereto)
given by or at the direction of the Board of Directors or any committee thereof, (ii) otherwise properly brought before the meeting
by or at the direction of the Board of Directors or any committee thereof, or (iii) otherwise properly brought before an annual
meeting by a stockholder (a) who is a stockholder of record of the Corporation at the time the notice provided for in this Article
IV is delivered to, or mailed and received by, the Secretary of the Corporation, on the record date for the determination of
stockholders of the Corporation entitled to vote at the meeting, and at the time of the meeting, (b) who is entitled to vote at the
meeting and (c) complies with the notice procedures set forth in this Article IV. In addition, any proposal of stockholder business
(other than the nomination of persons for election to the Board of Directors) must be a proper matter for stockholder action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>For business (other than the nomination of persons for election to the Board of Directors, which shall be governed by Article V
herein) to be properly brought before the annual meeting by a stockholder, the stockholder or stockholders of record intending to propose
the business must deliver a timely and proper advance notice to the Secretary of the Corporation that complies with the following requirements:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>to be timely, the advance notice must be in writing and must be delivered to, or mailed and received by, the Secretary of the Corporation
at the principal executive offices of the Corporation no earlier than one hundred and twenty (120) days, and no later than ninety (90)
days, prior to the first anniversary date of the prior year&rsquo;s annual meeting&#894; provided, however, that in the event that the
annual meeting is called for a date that is more than thirty (30) days before or more than sixty (60) days after such anniversary date
(or with respect to any other annual meeting of stockholders, including in the event that no annual meeting was held in the previous year),
notice by the proponent stockholder in order to be timely must be so delivered, or mailed and received by, the Secretary of the Corporation
at the principal executive offices of the Corporation, not earlier than the close of business on the 120th day prior to the annual meeting
and not later than the close of business on the later of the 90th day prior to the date of such annual meeting or, if the first &ldquo;Public
Announcement&rdquo; (as hereinafter defined in Section 9 of Article V) of the date of such annual meeting is less than one hundred (100)
days prior to the date of such annual meeting, the 10th day following the day on which Public Announcement of the date of such meeting
is first made by the Corporation. In no event shall any adjournment or postponement of an annual meeting, or the Public Announcement thereof,
commence a new time period (or extend any notice time period) for the giving of a stockholder&rsquo;s notice as described above&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>in addition, to be timely, a stockholder&rsquo;s notice shall further be updated and supplemented, if necessary, so that the information
provided or required to be provided in such notice shall be true and correct as of each of the record date for the meeting and the date
that is ten (10) business days prior to the meeting or any adjournment or postponement thereof, and such update and supplement shall be
delivered to, or mailed and received by, the Secretary of the Corporation at the principal executive offices of the Corporation not later
than five (5) business days after the record date for the meeting (in the case of the update and supplement required to be made as of
the record date), and not later than eight (8) business days prior to the date for the meeting, or if the meeting is adjourned or postponed,
on the first practicable date after any adjournment or postponement thereof (in the case of the update and supplement required to be made
as of ten (10) business days prior to the meeting or any adjournment or postponement thereof)&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>the proponent stockholder must disclose to the Corporation, as part of the advance notice, its name and address as they appear
on the Corporation&rsquo;s books and of any beneficial owner, if any, and their respective affiliates and associates or others acting
in concert therewith&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">(iv) the proponent
stockholder must disclose to the Corporation, as part of the advance notice, (a) the class or series and number of shares of capital
stock or other securities of the Corporation which are, directly or indirectly, owned of record or beneficially (within the meaning
of Rule 13d-3 under the Securities Exchange Act of 1934, as amended) by such proponent stockholder, (b) any option, warrant,
convertible security, stock appreciation right, or similar right with an exercise or conversion privilege or a settlement payment or
mechanism at a price related to any shares of capital stock or other securities of the Corporation or with a price or value derived
in whole or in part from the price or value of any shares of capital stock or other securities of the Corporation or any derivative,
synthetic, hedging, swap or similar transaction or arrangement having characteristics of a long or short position or ownership
interest in any shares of capital stock or other securities of the Corporation, whether or not any such instrument or right shall be
subject to settlement in the underlying shares of capital stock or other securities of the Corporation or otherwise, and any other
direct or indirect opportunity to profit or share in any profit derived from any increase or decrease in the price or value of
shares of capital stock or other securities of the Corporation directly or indirectly owned beneficially by such proponent
stockholder, (c) a reasonably detailed description of any proxy, agreement, arrangement, understanding or relationship pursuant to
which such proponent stockholder has given or received a right to vote, directly or indirectly, any shares of capital stock or other
securities of the Corporation, (d) a reasonably detailed description of any agreement, arrangement, understanding or relationship,
including any repurchase or similar so-called &ldquo;stock borrowing&rdquo; agreement or arrangement, which such proponent
stockholder has engaged in or is a party to, directly or indirectly, the purpose or effect of which is to mitigate loss to, reduce
the economic risk of shares of capital stock or other securities of the Corporation by, manage the risk of share price changes for,
or increase or decrease the voting power of, such proponent stockholder with respect to shares of capital stock or other securities
of the Corporation, or which provides, directly or indirectly, the opportunity to profit from any increase or decrease in the price
or value of the shares of capital stock or other securities of the Corporation, (e) any rights to dividends or other distributions
on the shares of any class or series of capital stock of the Corporation, directly or indirectly, owned beneficially by the
proponent stockholder that are separated or separable from the underlying shares of the Corporation, (f) any performance-related
fees (other than an asset based fee) that the proponent stockholder, directly or indirectly, is entitled to based on any increase or
decrease in the value of shares of any class or series of capital stock of the Corporation or any interests described in clause (d),
(g) any proportionate interest in any security of the Corporation or derivative instruments held, directly or indirectly, by a
general or limited partnership or limited liability company or similar entity in which a proponent stockholder is a general partner
or, directly or indirectly, beneficially owns any interest in a general partner or is the manager or managing member or, directly or
indirectly, beneficially owns any interest in the manager or managing member of a limited liability company or similar entity, (h)
any Short Interest held by a proponent stockholder presently or within the last 12 months in any security of the Corporation (for
purposes of these By-Laws, a person shall be deemed to have a &ldquo;Short Interest&rdquo; in a security if such person, directly or
indirectly, though any contract, arrangement, understanding, relationship or otherwise, has the opportunity to profit or share in
any profit derived from any decrease in the value of the subject security), (i) any direct or indirect legal, economic or financial
interest (including Short Interest) of a proponent stockholder in the outcome of any (1) vote to be taken at any annual or special
meeting of stockholders of the Corporation or (2) any meeting of stockholders of any other entity with respect to any matter that is
related, directly or indirectly, to any business proposed by any proponent stockholder under Article IV, (j) any direct or indirect
legal, economic or financial interest (including Short Interest) in any principal competitor of the Corporation held by a proponent
stockholder, (k) any material pending or threatened action, suit or proceeding (whether civil, criminal, investigative,
administrative or otherwise) in which a proponent stockholder is, or is reasonably expected to be made, a party or material
participant involving the Corporation or any of its officers, directors or employees, or any affiliate of the Corporation, or any
officer, director or employee of such affiliate, and (l) any other information relating to such stockholder and beneficial owner, if
any, required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies
for the proposal pursuant to and in accordance with Section 14(a) of the Securities Exchange Act of 1934, as amended and the rules
and regulations promulgated thereunder&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>the proponent stockholder must also disclose to the Corporation, as part of the advance notice, all stock ownership information
required by the immediately preceding clause (iv) with respect to (a) the beneficial owner or beneficial owners of capital stock of the
Corporation, if different, on whose behalf the business proposed to be brought before the annual meeting is being brought, (b) any affiliate
or associate (each within the meaning of Rule 12b-2 under the Securities Exchange Act of 1934, as amended) of the proponent stockholder
or any such beneficial owner, (c) any stockholder or stockholder group with whom the proponent stockholder is acting in concert with,
whether or not such persons constitute a filing group for purposes of Schedule 13D, and (d) any other person or persons (including their
names) in connection with the proposal of such business&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>the proponent stockholder must represent to the Corporation, as part of the advance notice, whether the proponent intends individually
or as part of a group, to (x) deliver a proxy statement and/or form of proxy to holders of at least the percentage of the Corporation&rsquo;s
outstanding capital stock required to approve or adopt the proposal, and/or (y) to otherwise solicit proxies in support of such proposal&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">(vii) the proponent
stockholder must disclose to the Corporation, as part of its advance notice: (a) a reasonably brief description of the business
desired to be brought before the meeting, the reasons for conducting such business at the meeting and any material interest of such
stockholder and beneficial owner, if any, in such business, (b) the text of the proposal or business (including the text of any
resolutions proposed for consideration and in the event that such business includes a proposal to amend the By-Laws of the
Corporation, the language of the proposed amendment), and (c) a reasonably detailed description of all agreements, arrangements and
understandings between such proponent and the beneficial owner, if any, and any other person or persons (including their names) in
connection with the proposal of such business by such stockholder&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT>the proponent stockholder must provide a representation to the Corporation, as part of its advance notice, that the proponent stockholder
is a holder of record of capital stock of the Corporation entitled to vote at the meeting, will continue to be a stockholder of record
of the Corporation entitled to vote at such meeting through the date of such meeting and intends to appear in person or by proxy at the
meeting to propose the stockholder business specified in the notice&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">(ix)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>the proponent stockholder must provide, as part of its advance notice, a certification by the proponent stockholder of the accuracy
of the information set forth in the advance notice&#894; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>the proponent stockholder must provide, as part of its advance notice, the names and addresses of other stockholders (including
beneficial and record owners) known by the proponent stockholder to support the stockholder business to be proposed by the proponent stockholder
and, to the extent known, the class or series and number of all shares of capital stock of the Corporation owned beneficially or of record
by such other stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">3.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>In addition to the provisions of Section 2 of this Article IV, a stockholder shall also comply with all applicable requirements
of state law and all applicable requirements of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder,
with respect to the matters set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">4.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Nothing in these By-laws shall be deemed to affect any rights of stockholders to request the inclusion of proposals in the Corporation&rsquo;s
proxy statement pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended. Subject to Rule 14a-8 and Rule 14a-19 under
the Securities Exchange Act of 1934, as amended, nothing in these By-laws shall be construed to permit any stockholder, or give any stockholder
the right, to include or have disseminated or described in the Corporation&rsquo;s proxy statement any nomination of director or directors
or any other business proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">5.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Except as otherwise expressly provided in any applicable rule or regulation promulgated under the Securities Exchange Act of 1934,
as amended, only such business (other than the election of directors as set forth in Article V) shall be conducted at an annual meeting
of stockholders as shall have been brought before the meeting in accordance with the procedures of this Article IV. Except as otherwise
provided by law, the chairperson of the meeting shall have the power and duty (i) to determine whether any business proposed to be brought
before the meeting was proposed in accordance with the provisions of this Article IV (including whether the proponent stockholder solicited
(or are part of a group which solicited) or did not so solicit, as the case may be, proxies or votes in support of the proponent stockholder&rsquo;s
proposal in compliance with the proponent stockholder&rsquo;s representation as required by clause (vi) of Section 2 of Article IV) and
(ii) if any proposed business was not proposed in compliance with Article IV, to declare that such proposed business shall not be transacted.
Notwithstanding the foregoing provisions of this Article IV, unless otherwise required by law, if the proponent stockholder (or a qualified
representative of the proponent stockholder) does not appear at the annual meeting of stockholders of the Corporation to present the proposed
business, such proposed business shall not be transacted, notwithstanding that proxies in respect of such vote may have been received
by the Corporation. For purposes of this Section 5 of Article IV, to be considered a qualified representative of the proponent stockholder,
a person must be a duly authorized officer, manager or partner of such proponent stockholder or must be authorized by a writing executed
by such proponent stockholder or an electronic transmission delivered by such proponent stockholder to act for such proponent stockholder
as proxy at the meeting of stockholders and such person must produce such writing or electronic transmission, or a reliable reproduction
of the writing or electronic transmission, at the meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">ARTICLE V</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">STOCKHOLDER DIRECTOR NOMINATIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">1. At an annual meeting of stockholders, only
such nominations of persons for the election of directors shall be conducted as shall have been properly brought before the meeting.
To be properly brought before an annual meeting of stockholders, nominations of persons for election to the Board of Directors must
be: (i) specified in the notice of the meeting (or any supplement thereto) given by or at the direction of the Board of Directors or
any committee thereof, (ii) otherwise properly brought before the meeting by or at the direction of the Board of Directors or any
committee thereof, or (iii) otherwise properly brought before an annual meeting by a stockholder (a) who is a stockholder of record
of the Corporation at the time the notice provided for in this Article V is delivered to, or mailed and received by, the Secretary
of the Corporation, on the record date for the determination of stockholders of the Corporation entitled to vote at the meeting, and
at the time of the meeting, (b) who is entitled to vote at the meeting and (c) complies with the notice procedures set forth in this
Article V.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Notwithstanding anything in these By-laws to the contrary, for the nomination of persons for election to the Board of Directors
to be properly brought before the annual meeting by a stockholder, the stockholder or stockholders of record intending to propose such
nominations must deliver a timely and proper advance notice to the Secretary of the Corporation that complies with the following requirements:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 80.05pt">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>to be timely, the advance notice must be in writing and must be delivered to, or mailed and received by, the Secretary of the Corporation
at the principal executive offices of the Corporation no earlier than one hundred and twenty (120) days, and no later than ninety (90)
days, prior to the first anniversary date of the prior year&rsquo;s annual meeting&#894; provided, however, that in the event that the
annual meeting is called for a date that is more than thirty (30) days before or more than sixty (60) days after such anniversary date
(or with respect to any other annual meeting of stockholders, including in the event that no annual meeting was held in the previous year),
notice by the proponent stockholder in order to be timely must be so delivered, or mailed and received by, the Secretary of the Corporation
at the principal executive offices of the Corporation, not earlier than the close of business on the 120th day prior to the annual meeting
and not later than the close of business on the later of the 90th day prior to the date of such annual meeting or, if the first Public
Announcement of the date of such annual meeting is less than one hundred (100) days prior to the date of such annual meeting, the 10th
day following the day on which Public Announcement of the date of such meeting is first made by the Corporation. In no event shall any
adjournment or postponement of an annual meeting, or the Public Announcement thereof, commence a new time period (or extend any notice
time period) for the giving of a stockholder&rsquo;s notice as described above&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>in addition, to be timely, a stockholder&rsquo;s notice shall further be updated and supplemented, if necessary, so that the information
provided or required to be provided in such notice shall be true and correct as of each of the record date for the meeting and the date
that is ten (10) business days prior to the meeting or any adjournment or postponement thereof, and such update and supplement shall be
delivered to, or mailed and received by, the Secretary of the Corporation at the principal executive offices of the Corporation not later
than five (5) business days after the record date for the meeting (in the case of the update and supplement required to be made as of
the record date), and not later than eight (8) business days prior to the date for the meeting, or if the meeting is adjourned or postponed,
on the first practicable date after any adjournment or postponement thereof (in the case of the update and supplement required to be made
as of ten (10) business days prior to the meeting or any adjournment or postponement thereof)&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>in the event that the number of directors to be elected to the Board of Directors is increased by the Board of Directors, and there
is no Public Announcement by the Corporation naming all of the nominees for director or specifying the size of the increased Board of
Directors at least one hundred (100) days prior to the first anniversary of the preceding year&rsquo;s annual meeting, a stockholder&rsquo;s
notice required by Section 2 of this Article V shall also be considered timely, but only with respect to nominees for any new positions
created by such increase, if it shall be delivered to, or mailed and received by, the Secretary of the Corporation at the principal executive
offices of the Corporation not later than the close of business on the 10th day following the day on which such Public Announcement is
first made by the Corporation&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>the proponent stockholder must disclose to the Corporation, as part of the advance notice, its name and address as they appear
on the Corporation&rsquo;s books and of any beneficial owner, if any, and their respective affiliates and associates or others acting
in concert therewith&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">(v) the proponent
stockholder must disclose to the Corporation, as part of the advance notice, (a) the class or series and number of shares of capital
stock or other securities of the Corporation which are, directly or indirectly, owned of record or beneficially (within the meaning
of Rule 13d-3 under the Securities Exchange Act of 1934, as amended) by such proponent stockholder, (b) any option, warrant,
convertible security, stock appreciation right, or similar right with an exercise or conversion privilege or a settlement payment or
mechanism at a price related to any shares of capital stock or other securities of the Corporation or with a price or value derived
in whole or in part from the price or value of any shares of capital stock or other securities of the Corporation or any derivative,
synthetic, hedging, swap or similar transaction or arrangement having characteristics of a long or short position or ownership
interest in any shares of capital stock or other securities of the Corporation, whether or not any such instrument or right shall be
subject to settlement in the underlying shares of capital stock or other securities of the Corporation or otherwise, and any other
direct or indirect opportunity to profit or share in any profit derived from any increase or decrease in the price or value of
shares of capital stock or other securities of the Corporation directly or indirectly owned beneficially by such proponent
stockholder, (c) a reasonably detailed description of any proxy, agreement, arrangement, understanding or relationship pursuant to
which such proponent stockholder has given or received a right to vote, directly or indirectly, any shares of capital stock or other
securities of the Corporation, (d) a reasonably detailed description of any agreement, arrangement, understanding or relationship,
including any repurchase or similar so-called &ldquo;stock borrowing&rdquo; agreement or arrangement, which such proponent
stockholder has engaged in or is a party to, directly or indirectly, the purpose or effect of which is to mitigate loss to, reduce
the economic risk of shares of capital stock or other securities of the Corporation by, manage the risk of share price changes for,
or increase or decrease the voting power of, such proponent stockholder with respect to shares of capital stock or other securities
of the Corporation, or which provides, directly or indirectly, the opportunity to profit from any increase or decrease in the price
or value of the shares of capital stock or other securities of the Corporation, (e) any rights to dividends or other distributions
on the shares of any class or series of capital stock of the Corporation, directly or indirectly, owned beneficially by the
proponent stockholder that are separated or separable from the underlying shares of the Corporation, (f) any performance-related
fees (other than an asset based fee) that the proponent stockholder, directly or indirectly, is entitled to based on any increase or
decrease in the value of shares of any class or series of capital stock of the Corporation or any interests described in clause (d),
(g) any proportionate interest in any security of the Corporation or derivative instruments held, directly or indirectly, by a
general or limited partnership or limited liability company or similar entity in which a proponent stockholder is a general partner
or, directly or indirectly, beneficially owns any interest in a general partner or is the manager or managing member or, directly or
indirectly, beneficially owns any interest in the manager or managing member of a limited liability company or similar entity, (h)
any Short Interest held by a proponent stockholder presently or within the last 12 months in any security of the Corporation, (i)
any direct or indirect legal, economic or financial interest (including Short Interest) of a proponent stockholder in the outcome of
any (1) vote to be taken at any annual or special meeting of stockholders of the Corporation or (2) any meeting of stockholders of
any other entity with respect to any matter that is related, directly or indirectly, to any nomination proposed by any proponent
stockholder under Article V, (j) any direct or indirect legal, economic or financial interest (including Short Interest) in any
principal competitor of the Corporation held by a proponent stockholder, (k) any material pending or threatened action, suit or
proceeding (whether civil, criminal, investigative, administrative or otherwise) in which a proponent stockholder is, or is
reasonably expected to be made, a party or material participant involving the Corporation or any of its officers, directors or
employees, or any affiliate of the Corporation, or any officer, director or employee of such affiliate, and (l) any other
information relating to such stockholder and beneficial owner, if any, required to be disclosed in a proxy statement or other
filings required to be made in connection with solicitations of proxies for the election of directors in an election contest
pursuant to and in accordance with Section 14(a) of the Securities Exchange Act of 1934, as amended and the rules and regulations
promulgated thereunder (collectively, the information in this clause (v), the &ldquo;Stockholder Information&rdquo;)&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT> the proponent stockholder must also disclose to the Corporation, as part of the advance notice, all stock ownership information
required by the immediately preceding clause (v) with respect to (a) the beneficial owner or beneficial owners of capital stock of the
Corporation, if different, on whose behalf the nomination proposed to be brought before the annual meeting is made, (b) any affiliate
or associate (each within the meaning of Rule 12b-2 under the Securities Exchange Act of 1934, as amended) of the proponent stockholder
or any such beneficial owner, and, (c) any stockholder or stockholder group with whom the proponent stockholder is acting in concert with,
whether or not such persons constitute a filing group for purposes of Schedule 13D, and (d) any other person or persons (including their
names) in connection with the proposal of such nomination&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 80.05pt">(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT> the proponent stockholder must represent to the Corporation, as part of the advance notice, whether the proponent or any of its
respective affiliates, associates or others acting in concert therewith intends individually or as part of a group, to (a) deliver a proxy
statement and/or form of proxy to holders of at least the percentage of the Corporation&rsquo;s outstanding capital stock required to
elect the nominee and/or (b) to otherwise solicit proxies in support of such nomination, including to solicit proxies in support of director
nominees other than the Corporation&rsquo;s nominees in accordance with Rule 14a-19 under the Securities Exchange Act of 1934, as amended&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT>the proponent stockholder must disclose to the Corporation, as part of the advance notice, as to each person whom the proponent
stockholder proposes to nominate for election as a director (a) all information about the proposed nominees that would be required to
be to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for the election
of directors in a contested election pursuant to Section 14 of the Securities Exchange Act of 1934, as amended, and the rules and regulations
promulgated thereunder (including such person&rsquo;s written consent to being named in the proxy statement, including the Corporation&rsquo;s
proxy statement, as a nominee of the proponent stockholder and to serving as a director if elected), (b) a complete and accurate description
of all direct and indirect compensation and other material monetary agreements, arrangements and understandings (whether written or oral)
during the past three years, and any other material relationships, between or among such stockholder and beneficial owner, if any, and
their respective affiliates and associates, or others acting in concert therewith, on the one hand, and each proposed nominee, and his
or her respective affiliates and associates, or others acting in concert therewith, on the other hand, including, without limitation all
information that would be required to be disclosed pursuant to Rule 404 promulgated under Regulation S-K if the stockholder making the
nomination and any beneficial owner on whose behalf the nomination is made, if any, or any affiliate or associate thereof or person acting
in concert therewith, were the &ldquo;registrant&rdquo; for purposes of such rule and such proposed nominee were a director or executive
officer of such registrant, (c) a completed and signed questionnaire, representation and agreement and any and all other information required
by Section 4 of Article V, and (d) the Stockholder Information for such person and any member of the immediate family of such person,
or any affiliate or associate of such person, or any person acting in concert therewith&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">(ix)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>the proponent stockholder must provide a representation to the Corporation, as part of its advance notice, that the proponent stockholder
is a holder of record of capital stock of the Corporation entitled to vote at the meeting, will continue to be a stockholder of record
of the Corporation entitled to vote at such meeting through the date of such meeting and intends to appear in person or by proxy at the
meeting to propose the nomination(s) specified in the notice&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>the proponent stockholder must provide, as part of its advance notice, a certification by the proponent stockholder of the accuracy
of the information set forth in the advance notice&#894; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">(xi)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>the proponent stockholder must provide, as part of its advance notice, the names and addresses of other stockholders (including
beneficial and record owners) known by the proponent stockholder to support the nomination(s) made by the proponent stockholder and, to
the extent known, the class or series and number of all shares of capital stock of the Corporation owned beneficially or of record by
such other stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">3. Nominations of persons
for election to the Board of Directors may be made at a special meeting of stockholders at which directors are to be elected
pursuant to the Corporation&rsquo;s notice of meeting (i) by or at the direction of the Board of Directors or any committee thereof
or (ii) provided that the Board of Directors has determined that directors shall be elected at such meeting, by any stockholder of
the Corporation (a) who is a stockholder of record of the Corporation at the time the notice provided for in this Article V is
delivered to, or mailed and received by, the Secretary of the Corporation, on the record date for the determination of stockholders
of the Corporation entitled to vote at the meeting, and at the time of the meeting, (b) who is entitled to vote at the meeting and
(c) complies with the notice procedures set forth in this Article V. In the event the Corporation calls a special meeting of
stockholders for the purpose of electing one (1) or more directors to the Board of Directors, any such proponent stockholder
entitled to vote in such election of directors may nominate a person or persons (as the case may be) for election to such
position(s) as specified in the Corporation&rsquo;s notice of meeting, if the notice required by Section 2 of Article V shall be
delivered to, or mailed and received by, the Secretary of the Corporation at the principal executive offices of the Corporation no
earlier than one hundred and twenty (120) days prior to the special meeting, and no later than ninety (90) days prior to the special
meeting, or the tenth (10th) day following the day on which the Corporation first makes a public announcement of the date of the
special meeting at which directors are to be elected. In no event shall the public announcement of an adjournment or postponement of
a special meeting commence a new time period (or extend any time period) for the giving of a stockholder&rsquo;s notice as described
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">4.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>In addition to the requirements set forth elsewhere in these By-Laws, to be eligible to be a nominee for election or re-election
as a director of the Corporation, such proposed nominee or a person on such proposed nominee&rsquo;s behalf must deliver (with respect
to a nomination made by a proponent pursuant to Section 2 of Article V, in accordance with the time periods for delivery of timely notice
under Section 2 of Article V), to the Secretary of the Corporation at the principal executive offices of the Corporation a completed and
signed questionnaire with respect to the background and qualifications of such proposed nominee and the background of any other person
or entity on whose behalf the nomination is being made (which questionnaire shall be provided by the Secretary of the Corporation upon
written request of any stockholder of record identified by name within ten business days of such written request) and a written representation
and agreement (in the form provided by the Secretary of the Corporation upon written request of any stockholder of record identified by
name within ten business days of such written request) that such proposed nominee (i) is not and will not become a party to (a) any agreement,
arrangement or understanding with, and has not given any commitment or assurance to, any person or entity as to how such proposed nominee,
if elected as a director of the Corporation, will act or vote on any issue or question (a &ldquo;Voting Commitment&rdquo;) that has not
been disclosed to the Corporation or (b) any Voting Commitment that could limit or interfere with such proposed nominee&rsquo;s fiduciary
duties under applicable law, (ii) is not and will not become a party to any agreement, arrangement or understanding with any person or
entity other than the Corporation with respect to any direct or indirect compensation, reimbursement or indemnification in connection
with service or action as a director that has not been disclosed to the Corporation, and (iii) would be in compliance, if elected as a
director of the Corporation, and will comply with, all applicable publicly disclosed corporate governance, code of conduct and ethics,
conflict of interest, confidentiality, corporate opportunities, trading and any other policies and guidelines of the Corporation applicable
to directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">5.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Corporation may also require, as a condition to any such nomination being deemed properly brought before an annual or special
meeting, any proponent stockholder or proposed nominee to furnish such other information as may reasonably be required by the Corporation
to determine the eligibility of such proposed nominee to serve as an independent director of the Corporation or that could be material
to a reasonable stockholder&rsquo;s understanding of the independence, or lack thereof, of such nominee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">6.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>In addition, if the proponent stockholder has provided notice pursuant to Rule 14a-19(b) of the Securities Exchange Act of 1934,
as amended, the proponent stockholder shall deliver to the Corporation no later than ten (10) days prior to the date of the meeting or
any adjournment or postponement thereof reasonable evidence that it has complied with the requirements of Rule 14a-19 of the Securities
Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">7. Compliance with the
provisions of this Article V is the sole and exclusive method for stockholders to nominate candidates for election to the Board of
Directors at an annual or special meeting of stockholders. No person shall be eligible for election as a director of the Corporation
at an annual or special meeting of stockholders unless nominated in accordance with the procedures set forth in this Article V. The
number of nominees that a proponent stockholder may nominate for election at an annual or special meeting (or in the case of a
proponent stockholder giving the notice on behalf of a beneficial owner, the number of nominees a proponent stockholder may nominate
for election at the annual or special meeting on behalf of such beneficial owner) shall not exceed the number of directors to be
elected at such annual or special meeting. For the avoidance of doubt, a stockholder shall not be entitled to make additional or
substitute nominations at an annual or special meeting following the expiration of the time periods set forth in these By-Laws.
Unless otherwise required by law, if any proponent stockholder (i) provides notice pursuant to Rule 14a-19(b) under the Securities
Exchange Act of 1934, as amended, and (ii) subsequently fails to comply with any requirements of Rule 14a-19 of the Securities
Exchange Act of 1934, as amended, or any other rules or regulations thereunder, then the Corporation shall disregard any proxies or
votes solicited for such nominees and such nominations shall be disregarded. Except as otherwise provided by law or herein, the
chairperson of the meeting shall have the power and duty (i) to determine whether a nomination was made in accordance with the
provisions of this Article V (including whether the proponent stockholder or any of its respective affiliates, associates or others
acting in concert therewith solicited (or are part of a group which solicited) or did not so solicit, as the case may be, proxies or
votes in support of the proponent stockholder&rsquo;s nominee in compliance with the proponent stockholder&rsquo;s representation as
required by clause (vii) of Section 2 of Article V) and (ii) if any proposed nomination was not made in compliance with Article V,
to declare that such nomination shall be disregarded. Notwithstanding the foregoing provisions of Article V, unless otherwise
required by law, if the proponent stockholder (or a qualified representative of the proponent stockholder) does not appear at the
annual or special meeting of stockholders of the Corporation to present a nomination, such nomination shall be disregarded,
notwithstanding that proxies in respect of such vote may have been received by the Corporation. For purposes of this Section 7 of
Article V, to be considered a qualified representative of the proponent stockholder, a person must be a duly authorized officer,
manager or partner of such proponent stockholder or must be authorized by a writing executed by such proponent stockholder or an
electronic transmission delivered by such proponent stockholder to act for such proponent stockholder as proxy at the meeting of
stockholders and such person must produce such writing or electronic transmission, or a reliable reproduction of the writing or
electronic transmission, at the meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">8.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>In addition to the provisions of this Article V, a stockholder shall also comply with all applicable requirements of state law
and all applicable requirements of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder, with respect
to the matters set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">9.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>For purposes of these By-laws, &ldquo;Public Announcement&rdquo; shall mean disclosure in a press release reported by a national
news service or in a document publicly filed by the Corporation with the Securities and Exchange Commission pursuant to Section 13, 14
or 15(d) of the Securities Exchange Act of 1934, as amended and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">ARTICLE VI</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">DIRECTORS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 58.5pt">1.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The business and affairs of the Corporation shall be managed under the direction of a Board of Directors, which may exercise all
such powers and authority for and on behalf of the Corporation as shall be permitted by law, the Certificate of Incorporation or these
By-laws. Each of the directors shall hold office until the next annual meeting of stockholders and until his or her successor has been
elected and qualified or until his or her earlier death, disqualification, resignation or removal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 58.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 58.5pt">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Board of Directors is empowered to appoint a Chairman of the Board of Directors. The Chairman shall act as chairman of all
meetings of the Board of Directors and as the presiding person at all special and annual meetings of stockholders, unless the Board of
Directors shall appoint a different individual as chairman of any meeting of the Board of Directors or as the presiding person at any
special or annual meeting of stockholders, and the chairman or presiding person shall have control over the agenda of any such meetings,
all in accordance with the provisions of these By-laws and the Certificate of Incorporation. The Chairman shall perform such other duties
as may from time to time be assigned to him by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 58.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 58.5pt">3.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Board of Directors may hold their meetings within or outside of the State of Delaware, at such place or places as it may from
time to time determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 58.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 58.5pt">4.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The number of directors comprising the Board of Directors shall be such number as may be from time to time fixed exclusively by
resolution of the Board of Directors. In case of any increase in the number of directors, a majority of the remaining members of the Board
of Directors, although such majority is less than a quorum, shall have the sole and exclusive power and authority to elect each additional
director to fill any newly created directorship, to hold office until the next annual meeting of stockholders and until his or her successor
is elected and qualified or his or her earlier death, disqualification, resignation or removal. No decrease in the number of directors
shall shorten the term of any incumbent director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 58.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 58.5pt"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 58.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 58.5pt">5. If any directorship
becomes vacant, by reason of death, resignation, disqualification, removal or otherwise, a majority of the directors then in office,
although less than a quorum, shall have the sole and exclusive authority to fill the vacancy by electing a successor who shall hold
office until the next annual meeting of stockholders and until his or her successor is elected and qualified or his or her earlier
death, resignation, disqualification or removal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 58.5pt">6.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Any director may resign at any time by giving notice of his or her resignation to the Corporation in writing or by electronic transmission.
Any such resignation shall take effect upon receipt thereof by the Corporation, or at such later time or date as may be specified therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 58.5pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">ARTICLE VII</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">COMMITTEES OF DIRECTORS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">1.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Board of Directors may designate an Executive Committee and one or more other committees, each such committee to consist of
one or more directors of the Corporation. The Executive Committee shall have and may exercise all the powers and authority of the Board
of Directors in the management of the business and affairs of the Corporation (except as otherwise expressly limited by statute), including
the power and authority to declare dividends and to authorize the issuance of stock, and may authorize the seal of the Corporation to
be affixed to all papers which may require it. Each such committee shall have such of the powers and authority of the Board of Directors
as may be provided from time to time in resolutions adopted by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The requirements with respect to the manner in which the Executive Committee and each such other committee shall hold meetings
and take actions shall be set forth in the resolutions of the Board of Directors designating the Executive Committee or such other committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">ARTICLE VIII</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">MEETINGS OF DIRECTORS&#894; ACTION WITHOUT
A MEETING</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">1.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Regular meetings of the Board of Directors may be held without notice at such time and place, either within or without the State
of Delaware, as may be determined from time to time by resolution of the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Special meetings of the Board of Directors shall be held whenever called by the President of the Corporation or the majority of
the directors then in office on at least 24 hours&rsquo; notice to each director. Except as may be otherwise specifically provided by statute,
by the Certificate of Incorporation or by these By-laws, the purpose or purposes of any such special meeting need not be stated in such
notice, although the time and place of the meeting shall be stated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">3.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>At all meetings of the Board of Directors, the presence in person of a majority of the total number of directors shall be necessary
and sufficient to constitute a quorum for the transaction of business, and, except as otherwise provided by statute, by the Certificate
of Incorporation or by these By-laws, if a quorum shall be present the act of a majority of the directors present shall be the act of
the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">4.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Any action required or permitted to be taken at any meeting of the Board of Directors or of any committee thereof may be taken
without a meeting if all the members of the Board of Directors or such committee, as the case may be, consent thereto in writing or by
electronic transmission and any consent may be documented, signed and delivered in any manner permitted by Section 116 of the General
Corporation Law of the State of Delaware. After an action is taken, the consent or consents or electronic transmissions shall be filed
with the minutes of proceedings of the Board of Directors or committee, in the same paper or electronic form as the minutes are maintained.
Any director may participate in a meeting of the Board of Directors, or any committee designated by the Board of Directors, by means of
a conference telephone or other communications equipment by means of which all persons participating in the meeting can hear each other,
and participation in a meeting pursuant to this sentence shall constitute presence in person at such meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">ARTICLE IX</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">OFFICERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 63pt">1. The officers of the
Corporation shall be chosen by the Board of Directors and shall be a Chief Executive Officer, a President, one or more Vice
Presidents, a Secretary and a Treasurer. The Board of Directors may also choose one or more Assistant Secretaries and Assistant
Treasurers, and such other officers as it shall deem necessary. Any number of offices may be held by the same person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 63pt">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The salaries of all officers of the Corporation shall be fixed by the Board of Directors, or in such manner as the Board of Directors
may prescribe.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 63pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 63pt">3.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The officers of the Corporation shall hold office until their successors are elected and qualified, or until their earlier resignation
or removal. Any officer may be at any time removed from office by the Board of Directors, with or without cause. If the office of any
officer becomes vacant for any reason, the vacancy may be filled by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 63pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 63pt">4.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Any officer may resign at any time by giving notice of his or her resignation to the Corporation in writing or by electronic transmission.
Any such resignation shall take effect upon receipt thereof by the Corporation or at such later date as may be specified therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 63pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 63pt">5.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Chief Executive Officer shall have general supervision and direction of the business and affairs of the Corporation, subject,
however, to the direction and control of the Board of Directors. The Chief Executive Officer may sign and execute in the name of the Corporation
deeds, mortgages, bond, contracts or other instruments. The Chief Executive Officer shall perform all duties incident to the office of
the Chief Executive Officer and shall, when requested, counsel with and advise the other officers of the Corporation and shall perform
such other duties as the Board of Directors may from time to time determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 63pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 63pt">6.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The President shall have such powers and perform such duties as from time to time may be assigned to him by the Chief Executive
Officer or the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 63pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 63pt">7.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Vice Presidents shall have such powers and duties as may be delegated to them by the Chief Executive Officer or the Board of
Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 63pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 63pt">8.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Secretary shall perform all duties incident to the office of the Secretary and shall have such powers and duties as may be
delegated to him by the Chief Executive Officer or the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 63pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 63pt">9.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Assistant Secretary shall, in case of the absence of the Secretary, perform the duties and exercise the powers of the Secretary,
and shall have such other powers and duties as may be delegated to them by the Chief Executive Officer or the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 63pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 63pt">10.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Treasurer shall have the custody of the corporate funds and securities, and shall deposit or cause to be deposited under his
or her direction all moneys and other valuable effects in the name and to the credit of the Corporation in such depositories as may be
designated by the Board of Directors or pursuant to authority granted by it. He shall render to the Chief Executive Officer and the Board
of Directors whenever they may require it an account of all his or her transactions as Treasurer and of the financial condition of the
Corporation. He shall have such other powers and duties as may be delegated to him by the Chief Executive Officer or the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 63pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 63pt">11.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Assistant Treasurer shall, in case of the absence of the Treasurer, perform the duties and exercise the powers of the Treasurer,
and shall have such other powers and duties as may be delegated to them by the Chief Executive Officer or the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 63pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">ARTICLE X</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">FORM OF CERTIFICATES&#894; UNCERTIFICATED
SHARES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt">Shares of the capital stock of the Corporation may be certificated
or uncertificated, as provided under the General Corporation Law of the State of Delaware. Each stockholder holding certificated shares
of capital stock of the Corporation, upon written request to the transfer agent or registrar of the Corporation, shall be entitled to
a certificate representing such shares of capital stock of the Corporation in such form as may from time to time be prescribed by the
Board of Directors. Any such certificate shall be signed by any two authorized officers of the Corporation, which shall include, without
limitation, the Chairman of the Board of Directors, the Chief Executive Officer, the President, any Vice President, the Treasurer, any
Assistant Treasurer, the Secretary and any Assistant Secretary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">ARTICLE XI</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">FISCAL YEAR</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt">The fiscal year of the Corporation shall be as determined from
time to time by resolution duly adopted by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">ARTICLE XII</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">NOTICES AND WAIVERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">1.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Whenever by statute, by the Certificate of Incorporation or by these By-laws it is provided that notice shall be given to any director,
such provision shall not be construed to require personal notice, but such notice may be given in writing, by mail, by depositing the
same in the United States mail, postage prepaid, directed to such director at his or her address as it appears on the records of the Corporation,
and such notice shall be deemed to be given at the time when the same shall be thus deposited. Notice of meetings of the Board of Directors
may also be given to any director by telephone or by electronic transmission, and in the latter event the notice shall be deemed to be
given at the time such notice, addressed to such director at the address hereinabove provided, is transmitted by facsimile, electronic
mail or other electronic transmission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Whenever by statute, by the Certificate of Incorporation or by these By-laws it is provided that notice shall be given to any stockholder,
such provision shall not be construed to require personal notice, but such notice may be given in writing, by mail, by depositing the
same in the United States mail, postage prepaid, directed to such stockholder at his or her mailing address as it appears on the records
of the Corporation, and such notice shall be deemed to be given at the time when the same shall be thus deposited. Such notice may also
be given (i) by courier service, and such notice shall be deemed to be given upon the earlier of when the notice is received or left at
the stockholder&rsquo;s address or (ii) by electronic transmission directed to the stockholder&rsquo;s electronic mail address as it appears
on the records of the Corporation, and such notice shall be deemed to be given when directed to such stockholder&rsquo;s electronic mail
address unless the stockholder has notified the Corporation in writing or by electronic transmission of an objection to receiving notice
by electronic mail or such notice is prohibited by Section 232(e) of the General Corporation Law of the State of Delaware. A notice by
electronic mail will include a prominent legend that the communication is an important notice regarding the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">3.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Without limiting the manner by which notice otherwise may be given effectively to stockholders, any notice to stockholders given
by the Corporation under any provision of the General Corporation Law of the State of Delaware, the Certificate of Incorporation, or these
By-laws shall be effective if given by another form of electronic transmission consented to by the stockholder to whom the notice is given.
Any such consent shall be revocable by the stockholder by written notice or electronic transmission to the Corporation. Any such consent
shall be deemed revoked if (i) the Corporation is unable to deliver by electronic transmission two (2) consecutive notices given by the
Corporation in accordance with such consent and (ii) such inability becomes known to the Secretary or an Assistant Secretary or to the
transfer agent, or other person responsible for the giving of notice&#894; provided, however, the inadvertent failure to discover such
inability shall not invalidate any meeting or other action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">4. Notice given pursuant
to Section 3 of this Article XII shall be deemed given: (i) if by facsimile telecommunication, when directed to a number at which
the stockholder has consented to receive notice&#894; (ii) if by a posting on an electronic network together with separate notice to
the stockholder of such specific posting, upon the later of (A) such posting and (B) the giving of such separate notice&#894; and
(iii) if by any other form of electronic transmission, when directed to the stockholder. An affidavit of the Secretary or an
Assistant Secretary or of the transfer agent or other agent of the Corporation that the notice has been given shall, in the absence
of fraud, be prima facie evidence of the facts stated therein. For purposes of this Article XII, &ldquo;electronic
transmission&rdquo; means any form of communication, not directly involving the physical transmission of paper, including the use
of, or participation in, 1 or more electronic networks or databases (including 1 or more distributed electronic networks or
databases), that creates a record that may be retained, retrieved and reviewed by a recipient thereof, and that may be directly
reproduced in paper form by such a recipient through an automated process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">5.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Whenever by statute, by the Certificate of Incorporation or by these By-laws a notice is required to be given, a written waiver
thereof, signed by the person entitled to notice, or a waiver by electronic transmission by the person entitled to notice, whether before
or after the time stated therein, shall be deemed equivalent to notice. Attendance of any stockholder or director at any meeting thereof
shall constitute a waiver of notice of such meeting by such stockholder or director, as the case may be, except as otherwise provided
by statute.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">ARTICLE XIII</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">INDEMNIFICATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">1.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Corporation shall indemnify to the maximum extent permitted by law any person who was or is a party or is threatened to be
made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative
(other than an action by or in the right of the corporation) by reason of the fact that such person is or was a director or officer of
the Corporation, or is or was serving at the request of the Corporation as a director or officer of another corporation, partnership,
joint venture, trust or other enterprise, against expenses (including attorneys&rsquo; fees), judgments, fines and amounts paid in settlement
actually and reasonably incurred by such person in connection with such action, suit or proceeding if such person acted in good faith
and in a manner such person reasonably believed to be in or not opposed to the best interests of the Corporation, and, with respect to
any criminal action or proceeding, had no reasonable cause to believe such person&rsquo;s conduct was unlawful. The termination of any
action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not,
of itself, create a presumption that the person did not act in good faith and in a manner which such person reasonably believed to be
in or not opposed to the best interests of the Corporation, and, with respect to any criminal action or proceeding, had reasonable cause
to believe that such person&rsquo;s conduct was unlawful. Notwithstanding the provisions of this Section 1, except as otherwise provided
in Section 4 of this Article XIII, the Corporation shall be required to indemnify any person referenced in this Section 1 in connection
with an action, suit or proceeding (or part thereof) commenced by such person only if the commencement of such action, suit or proceeding
(or part thereof) by the person was authorized in the specific case by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Corporation shall indemnify to the maximum extent permitted by law any person who was or is a party or is threatened to be
made a party to any threatened, pending or completed action or suit by or in the right of the Corporation to procure a judgment in its
favor by reason of the fact that such person is or was a director or officer of the corporation, or is or was serving at the request of
the Corporation as a director or officer of another corporation, partnership, joint venture, trust or other enterprise against expenses
(including attorneys&rsquo; fees) actually and reasonably incurred by such person in connection with the defense or settlement of such
action or suit if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best
interests of the Corporation and except that no such indemnification shall be made in respect of any claim, issue or matter as to which
such person shall have been adjudged to be liable to the Corporation unless and only to the extent that the Court of Chancery of the State
of Delaware (the &ldquo;Court of Chancery&rdquo;) or the court in which such action or suit was brought shall determine upon application
that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled
to indemnity for such expenses which such Court of Chancery or such other court shall deem proper.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">3.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Expenses (including attorneys&rsquo; fees) incurred by a present or former officer or director in defending any civil, criminal,
administrative or investigative action, suit or proceeding shall be paid by the Corporation in advance of the final disposition of such
action, suit or proceeding upon receipt of an undertaking by or on behalf of such director or officer to repay such amount if it shall
ultimately be determined that such person is not entitled to be indemnified by the Corporation as authorized in this Article XIII. Such
expenses (including attorneys&rsquo; fees) incurred by employees and agents may be so paid upon such terms and conditions, if any, as
the Corporation deems appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">4. The indemnification
and advancement of expenses provided by, or granted pursuant to, the other Sections of this Article XIII shall not be deemed
exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under any By-law,
agreement, vote of stockholders or disinterested directors or otherwise, both as to action in such person&rsquo;s official capacity
and as to action in another capacity while holding such office.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">5.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Corporation may, but shall not be required to, purchase and maintain insurance on behalf of any person who is or was a director,
officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee
or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against such person
and incurred by such person in any such capacity, or arising out of such person&rsquo;s status as such, whether or not the Corporation
would have the power to indemnify such person against such liability under the provisions of this Article XIII.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">6.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>For purposes of this Article XIII, references to &ldquo;the Corporation&rdquo; shall include, in addition to the resulting corporation,
any constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate
existence had continued, would have had power and authority to indemnify its directors or officers so that any person who is or was a
director or officer of such constituent corporation, or is or was serving at the request of such constituent corporation as a director
or officer of another corporation, partnership, joint venture, trust or other enterprise, shall stand in the same position under the provisions
of this Article XIII with respect to the resulting or surviving corporation as such person would have with respect to such constituent
corporation if its separate existence had continued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">7.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>For purposes of this Article XIII, references to &ldquo;other enterprises&rdquo; shall include employee benefit plans&#894; references
to &ldquo;fines&rdquo; shall include any excise taxes assessed on a person with respect to an employee benefit plan&#894; and references
to &ldquo;serving at the request of the Corporation&rdquo; shall include service as a director or officer of the Corporation which imposes
duties on, or involves services by, such director or officer with respect to an employee benefit plan, its participants or beneficiaries&#894;
and a person who acted in good faith and in a manner such person reasonably believed to be in the interest of the participants and beneficiaries
of an employee benefit plan shall be deemed to have acted in a manner &ldquo;not opposed to the best interests of the Corporation&rdquo;
as referred to in this Article XIII.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">8.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The indemnification and advancement of expenses provided by, or granted pursuant to, this Article XIII shall, unless otherwise
provided when authorized or ratified, continue as to a person who has ceased to be a director or officer and shall inure to the benefit
of the heirs, executors and administrators of such a person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">9.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>If this Article or any portion hereof shall be invalidated on any ground by any court of competent jurisdiction, then the Corporation
shall nevertheless indemnify each director or officer to the fullest extent not prohibited by any applicable portion of this Article that
shall not have been invalidated, or by any other applicable law. If this Article shall be invalid due to the application of the indemnification
provisions of another jurisdiction, then the Corporation shall indemnify each director and officer to the fullest extent under any other
applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">10.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Corporation may indemnify every person who was or is a party or is or was threatened to be made a party to any action, suit,
or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he is or was an employee or agent
of the corporation or, while an employee or agent of the Corporation, is or was serving at the request of the corporation as an employee
or agent or trustee of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, against expenses
(including counsel fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him in connection with such
action, suit or proceeding, to the extent permitted by Delaware law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">11.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Corporation&rsquo;s obligation, if any, to indemnify or to advance expenses to any person serving at its request as a director
or officer of another corporation, partnership, joint venture, trust or other enterprise shall be reduced by any amount such person may
collect as indemnification or advancement of expenses from such other corporation, partnership, joint venture, trust or other enterprise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 60.6pt">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">ARTICLE XIV</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">FORUM SELECTION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 60.6pt">1.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Unless the Corporation consents in writing to the selection of an alternative forum, the Court of Chancery (or, if and only if
the Court of Chancery lacks subject matter jurisdiction, any state or federal court located within the State of Delaware) and any appellate
court thereof shall be the sole and exclusive forum for (i) any derivative action, suit, or proceeding brought on behalf of the Corporation,
(ii) any action, suit, or proceeding asserting a claim of breach of fiduciary duty owed by any current or former director, officer, employee,
or stockholder of the Corporation to the Corporation or the Corporation&rsquo;s stockholders or any action asserting a claim for aiding
and abetting any such breach of fiduciary duty, (iii) any action, suit, or proceeding arising pursuant to any provision of the General
Corporation Law of the State of Delaware or the Certificate of Incorporation or these By-laws (as each may be amended from time to time),
(iv) any claim as to which the General Corporation Law of the State of Delaware confers jurisdiction upon the Court of Chancery, or (v)
any action, suit, or proceeding asserting a claim against the Corporation or its current or former directors, officers, employees, or
stockholders governed by the internal affairs doctrine, in each such case subject to such court having personal jurisdiction over the
indispensable parties named as defendants therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 59.4pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 60.6pt">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Unless the Corporation consents in writing to the selection of an alternative forum, to the fullest extent permitted by law, the
federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause
of action arising under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 59.4pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 60.6pt">3.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Notwithstanding the foregoing, the provisions of this Article XIV shall not apply to suits brought to enforce any liability or
duty created by the Securities Exchange Act of 1934, as amended, or any other claim for which the federal courts of the United States
have exclusive jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 59.4pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 60.6pt">4.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Any person or entity purchasing or otherwise acquiring any interest in shares of capital stock of the Corporation shall be deemed
to have notice of the provisions of this Article XIV. If any provision or provisions of this Article XIV shall be held to be invalid,
illegal or unenforceable as applied to any person or entity or circumstance for any reason whatsoever, then, to the fullest extent permitted
by law, the validity, legality and enforceability of such provisions in any other circumstance and of the remaining provisions of this
Article XIV (including, without limitation, each portion of any sentence of this Article XIV containing any such provision held to be
invalid, illegal or unenforceable that is not itself held to be invalid, illegal or unenforceable) and the application of such provision
to other persons or entities and circumstances shall not in any way be affected or impaired thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 59.4pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">ARTICLE XV</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">AMENDMENT OF BY-LAWS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt">The By-laws of the Corporation may be altered, amended or repealed,
and new By-laws may be adopted, by the Board of Directors. In addition, the By-laws of the Corporation may be altered, amended or repealed,
and new By-laws may be adopted, by the stockholders of the Corporation by the affirmative vote of the holders of a majority in voting
power of the outstanding shares of capital stock of the Corporation entitled to vote thereon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>



<P STYLE="margin: 0 0pt"></P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>3
<FILENAME>ea174308ex3-2_oramed.htm
<DESCRIPTION>FOURTH AMENDED AND RESTATED BY-LAWS, ADOPTED EFFECTIVE FEBRUARY 23, 2023 (MARKED COPY)
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.9pt 0pt 5pt; text-align: right; text-indent: 0.55pt">Exhibit 3.2</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.9pt 0pt 5pt; text-align: right; text-indent: 0.55pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.9pt 0pt 5pt; text-align: center; text-indent: 0.55pt">ORAMED PHARMACEUTICALS
INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><STRIKE STYLE="color: Red">&nbsp;</STRIKE></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.9pt 0pt 5pt; text-align: center; text-indent: 0.55pt"><STRIKE STYLE="color: Red">THIRD</STRIKE><FONT STYLE="letter-spacing: -0.35pt"><U STYLE="color: rgb(50,101,255)">FOURTH</U></FONT>
<FONT STYLE="letter-spacing: -0.3pt">AMENDED AND RESTATED BY-LAWS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 1.9pt 0pt 5pt; text-align: center; text-indent: 0.55pt"><FONT STYLE="letter-spacing: -0.3pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ARTICLE I</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="letter-spacing: -0.15pt">OFFICES</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.15pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.05pt">1.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT></FONT>The location of the registered office of the Corporation <STRIKE STYLE="color: Red">is 1013 Centre Road, Suite 403-B, in the City of Wilmington,
County of New Castle, Delaware 19805</STRIKE>, and the name of its registered agent <STRIKE STYLE="color: Red">at such address is Vcorp Services, LLC</STRIKE><U STYLE="color: rgb(50,101,255)">,
shall be as set forth in the Certificate of Incorporation</U>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.05pt">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT></FONT>The Corporation shall in addition to its registered office in the State of Delaware establish and maintain an office or
offices at such place or places as the Board of Directors may from time to time find necessary or desirable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 13.55pt 0pt 5pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ARTICLE II</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.3pt">CORPORATE</FONT>
<FONT STYLE="letter-spacing: -0.25pt">SEAL</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="letter-spacing: -0.25pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">The Corporation may or may not have a corporate seal, as
may be determined from time to time by the Board of Directors. If adopted, the corporate seal of the Corporation shall have inscribed
thereon the name of the Corporation and may be in such form as the Board of Directors may determine. Such seal may be used by causing
it or a facsimile thereof to be impressed, affixed or otherwise reproduced.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.7pt 0pt 5pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ARTICLE III</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="letter-spacing: -0.2pt">MEETINGS OF
STOCKHOLDERS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="letter-spacing: -0.2pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>All meetings of the stockholders shall be held at the registered office of the Corporation in the State of Delaware or at such
other place, as shall be determined from time to time by the Board of Directors. The Board of Directors may, in its sole discretion, determine
that any meeting of the stockholders shall not be held at any place, but may instead be held solely by means of remote communication in
accordance with Section 211 of the General Corporation Law of the State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.5in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The annual meeting of stockholders shall be held on such day and at such time as may be determined from time to time by resolution
of the Board of Directors, when they shall elect, by majority vote pursuant <FONT STYLE="letter-spacing: -0.45pt">to</FONT> Section 5
of this Article III, directors to hold office until the annual meeting of stockholders held next after their election and their successors
are respectively elected and qualified, or until their earlier death, disqualification, resignation or removal. Any other proper business
may be transacted at the annual meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.5in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The holders of at least one third (1/3) of the stock issued and outstanding and entitled to vote on the subject matter, present
in person or represented by proxy, shall constitute a quorum at all meetings of the stockholders for the transaction of business, except
as otherwise expressly provided by statute, by the Certificate of Incorporation or by these By-laws. If, however, such holders shall not
be present or represented at <FONT STYLE="letter-spacing: -0.45pt">any</FONT> meeting of the stockholders, the stockholders entitled to
vote on the subject matter, present in person or by proxy, shall have power to adjourn the meeting from time to time, without notice other
than announcement at the meeting (except as otherwise provided by statute). At such adjourned meeting at which a quorum is present, any
business may be transacted which might have been transacted at the meeting as originally notified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.5in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>At all <FONT STYLE="letter-spacing: -0.45pt">meetings</FONT> of the stockholders each stockholder having the right to vote on the
subject matter shall be entitled to vote in person, or by proxy <STRIKE STYLE="color: Red">appointed by an instrument in writing subscribed by such stockholder
and bearing a date not</STRIKE><U STYLE="color: rgb(50,101,255)">, but no proxy shall be voted or acted upon</U> more than three years <STRIKE STYLE="color: Red">prior to said meeting</STRIKE><U STYLE="color: rgb(50,101,255)">after
its date</U>, unless <STRIKE STYLE="color: Red">such instrument</STRIKE><U STYLE="color: rgb(50,101,255)">the proxy</U> provides for a longer period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.5in">5. <FONT STYLE="color: Red"><STRIKE>At</STRIKE></FONT><FONT STYLE="color: rgb(50,101,255)"><U>Unless
otherwise provided in the Certificate of Incorporation, at</U></FONT> each meeting of the stockholders each stockholder shall have one
vote for each share of capital stock having voting power, registered in his or her name on the books of the Corporation at the record
date fixed <FONT STYLE="color: rgb(50,101,255)"><U>for voting </U></FONT>in accordance with these By-laws, or otherwise determined, with
respect to such meeting.<FONT STYLE="color: Red"><STRIKE>&nbsp;&nbsp;Except as otherwise expressly provided</STRIKE></FONT> <FONT STYLE="color: rgb(50,101,255)"><U>Unless
a different or minimum vote is required</U></FONT> by <FONT STYLE="color: Red"><STRIKE>statute</STRIKE></FONT><FONT STYLE="color: rgb(50,101,255)"><U>law
or regulation applicable to the Corporation or its securities</U></FONT><FONT STYLE="font-size: 10pt">, by the Certificate of Incorporation
<FONT STYLE="color: Red"><STRIKE>or</STRIKE></FONT><FONT STYLE="color: rgb(50,101,255)"><U>,</U></FONT> by these By-laws <FONT STYLE="color: rgb(50,101,255); letter-spacing: -0.3pt"><U>or
by the rules or regulations of any stock exchange applicable to the Corporation, in which case such different or minimum vote shall be
the applicable vote on the matter</U></FONT></FONT><FONT STYLE="font-size: 10pt; letter-spacing: -0.3pt">, </FONT><FONT STYLE="font-size: 10pt">all
matters coming before any meeting of the stockholders<FONT STYLE="color: rgb(50,101,255)"><U>, including the election of directors,</U></FONT>
shall be decided by a majority of the votes cast by the holders of shares of stock present in person or represented by proxy at such
meeting and entitled to vote on the subject matter, a quorum being present. Votes cast shall include votes &ldquo;for&rdquo; and votes
&ldquo;against&rdquo; and exclude &ldquo;abstentions&rdquo; and &ldquo;broker non-votes&rdquo; with respect to the subject matter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.3pt 0pt 5pt; text-indent: 60.6pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.3pt 0pt 5pt; text-indent: 60.6pt"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.3pt 0pt 5pt; text-indent: 60.6pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">6.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Notice of each meeting of the stockholders shall be given to each stockholder entitled to vote thereat not less than ten (10) nor
more than sixty (60) days before the date of the meeting. Such notice shall state the place, date and hour of meeting, the record date
for determining the stockholders entitled to vote at the meeting, if such date is different from the record date for determining stockholders
entitled to notice of the meeting, the means of remote communications, if any, by which stockholders and proxy holders may be deemed to
be present in person and vote at such meeting and, in the case of a special meeting, the purpose or purposes for which the meeting is
called.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.3pt 0pt 5pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">7.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The <STRIKE STYLE="color: Red">Secretary</STRIKE><U STYLE="color: rgb(50,101,255)">Corporation</U> shall prepare <STRIKE STYLE="color: Red">and make</STRIKE>, no later than the tenth (10th) day before
each meeting of stockholders, a complete list of the stockholders entitled to vote at said meeting (provided, however, if the record date
for determining the stockholders entitled to vote is less than ten (10) days before the date of the meeting, the list shall reflect the
stockholders entitled to vote as of the tenth day before the meeting date), arranged in alphabetical order, showing the address of each
stockholder and <FONT STYLE="letter-spacing: -0.45pt">the</FONT> number of shares registered in the name of each stockholder. Such list
shall be open to the examination of any stockholder, for any purpose germane to the meeting for a period of 10 days ending on the day
before the meeting date, (a) on a reasonably accessible electronic network, provided that the information required to gain access to such
list is provided with the notice of the meeting, or (b) during ordinary business hours, at the principal place of business of the Corporation.
In the event that the Corporation determines to make the list available on an electronic network, the Corporation may take reasonable
steps to ensure that such information is available only to stockholders of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.3pt 0pt 5pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">8.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><FONT STYLE="letter-spacing: -0.45pt">Special</FONT> meetings of the stockholders, for any purpose or purposes, unless otherwise
prescribed by statute, may be called by the majority of the Board of Directors<U STYLE="color: rgb(50,101,255)">, but such meetings may not be called by any other person
or persons</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.3pt 0pt 5pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">9.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><FONT STYLE="letter-spacing: -0.45pt">Only</FONT> such business shall be conducted at a special meeting of stockholders as shall
have been brought before the meeting pursuant to the Corporation's notice of meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.3pt 0pt 5pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">10. <FONT STYLE="letter-spacing: -0.45pt">The </FONT>order
of business at each meeting of stockholders shall be determined by the <FONT STYLE="color: rgb(50,101,255); letter-spacing: -0.2pt"><U>person </U></FONT>presiding <FONT STYLE="color: rgb(50,101,255)"><U>over
the meeting.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.3pt 0pt 5pt; text-indent: 60.6pt"><U STYLE="text-decoration: none; color: rgb(50,101,255)">&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">11. <FONT STYLE="color: rgb(50,101,255)"><U>(a)
In order that the Corporation may <FONT STYLE="letter-spacing: -0.45pt">determine </FONT>the stockholders entitled to consent to
corporate action by consent and without a meeting of stockholders, the Board of Directors may fix a record date, which record date
shall not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors, and which date
shall not be more than ten (10) days after the date upon which the resolution fixing the record date is adopted by the Board of
Directors. Any stockholder of record seeking to have the stockholders authorize or take corporate action by consent in lieu of a
meeting of stockholders shall, by written notice delivered to the Secretary of the Corporation at the principal executive offices of
the Corporation, request that the Board of Directors fix a record date. The written notice must contain the information set forth in
Section 11(b) of this Article III. The Board of Directors shall promptly, but in all events within ten (10) days after the date on
which such written notice is received by the Secretary of the Corporation, determine the validity of the request, and if
appropriate, adopt a resolution fixing the record date (unless a record date has previously been fixed by the Board of Directors
pursuant to the first sentence of this Section 11(a) of Article III). If no record date has been fixed by the Board of Directors
pursuant to the first sentence of this Section 11(a) of Article III or otherwise within ten (10) days after the date on which such
written notice is received by the Secretary of the Corporation, the record date for determining stockholders entitled to consent to
corporate action by consent and without a meeting, when no prior action by the Board of Directors is required by applicable law,
shall be the first date after the expiration of such ten (10) day time period on which a signed consent setting forth the action
taken or proposed to be taken is delivered to the Corporation by delivery to its registered office in Delaware by hand or by
certified or registered mail, return receipt requested, to its principal place of business or to any </U></FONT>officer <FONT STYLE="color: rgb(50,101,255)"><U>or
agent of the Corporation having custody of the book in which proceedings of meetings of stockholders are recorded. If no record date
has been fixed by the Board of Directors pursuant to the first sentence of this Section 11(a) of Article III and prior action by the
Board of Directors is required by applicable law, the record date for determining stockholders entitled to consent to corporate
action by consent and without a meeting shall be at the close of business on the date on which the Board of Directors adopts the
resolution taking such prior action</U></FONT><FONT STYLE="font-size: 10pt">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.3pt 0pt 5pt; text-indent: 60.6pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.3pt 0pt 5pt; text-indent: 60.6pt"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.3pt 0pt 5pt; text-indent: 60.6pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in"><U STYLE="color: rgb(50,101,255)">(b)  Any
stockholder&rsquo;s notice required by Section 11(a) of Article III must describe the action that the stockholder proposes to take by
consent. For each such proposal, every notice by a stockholder must state (x) the information required by Section 2 of Article IV and
Section 2 of Article V as though such stockholder was intending to make a nomination or to bring any such business before a meeting of
stockholders and (y) the text of the proposal (including the text of any resolutions to be effected by consent and the language of any
proposed amendment to these By-Laws). In addition to the foregoing, the notice must state as to the stockholder giving the notice and
the beneficial owner, if any, on whose behalf the notice is given a representation whether the stockholder or the beneficial owner, if
any, intends or is part of a group which intends to (x) deliver a proxy statement and/or consent solicitation statement to stockholders
of at least the percentage of the Corporation&rsquo;s outstanding capital stock required to effect the action by consent either to solicit
consents or to solicit proxies to execute consents, and/or (y) otherwise solicit proxies or consents from stockholders in support of the
action to be taken by consent. The Corporation may require the stockholder of record and/or beneficial owner requesting a record date
for proposed stockholder action by consent to furnish such other information as it may reasonably require to determine the validity of
the request for a record date.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 85.05pt"><U STYLE="text-decoration: none; color: rgb(50,101,255)">&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in"><U STYLE="color: rgb(50,101,255)">(c)  In
the event of the delivery, in the manner provided by this Section 11 of Article III and applicable law, to the Corporation of consent
or consents to take corporate action and/or any related revocation or revocations, the Corporation shall engage independent inspectors
of elections for the purpose of performing promptly a ministerial review of the validity of the consents and any consent revocations.
For the purpose of permitting the inspectors to perform such review, no stockholder action by consent and without a meeting shall be effective
until such inspectors have completed their review, determined that the requisite number of valid and unrevoked consents delivered to the
Corporation in accordance with this Section 11 of Article III and applicable law have been obtained to authorize or take the action specified
in the consents, and certified such determination for entry in the records of the Corporation kept for the purpose of recording the proceedings
of meetings of stockholders. Nothing contained in this Section 11(c) of Article III shall in any way be construed to suggest or imply
that the Board of Directors or any stockholder shall not be entitled to contest the validity of any consent or revocation thereof, whether
before or after such certification by the independent inspectors, or to take any other action (including, without limitation, the commencement,
prosecution or defense of any litigation with respect thereto, and the seeking of injunctive relief in such litigation).</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 85.5pt"><U STYLE="text-decoration: none; color: rgb(50,101,255)">&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in"><U STYLE="color: rgb(50,101,255)">(d)  No
stockholder consent to corporate action without a meeting of stockholders shall be effective to take the corporate action referred to
therein unless, within sixty (60) days after the first date a consent is delivered in accordance with this Section 11 of Article III,
a valid consent or valid consents signed by a sufficient number of stockholders to take such action are delivered to the Corporation in
the manner prescribed in this Section 11 of Article III and applicable law, and not revoked.</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 3.1pt 0pt 2.55pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 3.1pt 0pt 2.55pt; text-align: center"><FONT STYLE="letter-spacing: -0.5pt">ARTICLE</FONT>
<FONT STYLE="letter-spacing: -0.45pt">IV</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.55pt; text-align: center"><FONT STYLE="letter-spacing: -0.25pt">STOCKHOLDER
PROPOSALS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.55pt; text-align: center"><FONT STYLE="letter-spacing: -0.25pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.35pt">1. <FONT STYLE="font-family: Times New Roman, Times, Serif"> </FONT></FONT>At
an annual meeting of stockholders, only such stockholder business shall be conducted as shall have been properly brought before the
meeting. To be properly brought before an annual meeting of stockholders, stockholder business (other than the nominations of
persons for election to the Board of Directors, which shall be set forth in Article V) must be: (i) specified in the notice of the
meeting (or any supplement thereto) given by or at the direction of the Board of Directors or any committee thereof, (ii) otherwise
properly brought before the meeting by or at the direction of the Board of Directors or any committee thereof, or (iii) otherwise
properly brought before an annual meeting by a stockholder (a) who is a stockholder of record of the Corporation at the time the
notice provided for in this Article IV is delivered to, or mailed and received by, the Secretary of the Corporation, on the record
date for the determination of stockholders of the Corporation entitled to vote at the meeting, and at the time of the meeting, (b)
who is entitled to vote at the meeting and (c) complies with the notice procedures set forth in this Article IV. In addition, any
proposal of stockholder business (other than the nomination of persons for election to the Board of Directors) must be a proper
matter for stockholder action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.6pt 0pt 5pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.6pt 0pt 5pt; text-indent: 60.6pt"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.6pt 0pt 5pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.35pt">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT></FONT>For business (other than the nomination of persons for election to the Board of Directors, which shall be governed by Article
V herein) to be properly brought before the annual meeting by a stockholder, the stockholder or stockholders of record intending to propose
the business must deliver a timely and proper advance notice to the Secretary of the Corporation that complies with the following requirements:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.6pt 0pt 5pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif"> </FONT>to be timely, the advance notice must be in writing and must be delivered to, or mailed and received by, the Secretary of the Corporation
at the principal executive offices of the Corporation no earlier than one hundred and twenty (120) days, and no later than ninety (90)
days, prior to the first anniversary date of the prior year&rsquo;s annual meeting&#894; provided, however, that in the event that the
annual meeting is called for a date that is more than thirty (30) days before or more than sixty (60) days after such anniversary date
(or with respect to any other annual meeting of stockholders, including in the event that no annual meeting was held in the previous year),
notice by the proponent stockholder in order to be timely must be so delivered, or mailed and received by, the Secretary of the Corporation
at the principal executive offices of the Corporation, not earlier than the close of business on the 120th day prior to the annual meeting
and not later than the close of business on the later of the 90th day prior to the date of such annual meeting or, if the first &ldquo;Public
Announcement&rdquo; (as hereinafter defined in Section 9 of Article V) of the date of such annual meeting is less than one hundred (100)
days prior to the date of such annual meeting, the 10th day following the day on which Public Announcement of the date of such meeting
is first made by the Corporation. In no event shall any adjournment or postponement of an annual meeting, or the Public Announcement thereof,
commence a new time period (or extend any notice time period) for the giving of a stockholder&rsquo;s notice as described above&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.25pt 0pt 5pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>in addition, to be timely, a stockholder&rsquo;s notice shall further be updated and supplemented, if necessary, so that the information
provided or required to be provided in such notice shall be true and correct as of each of the record date for the meeting and the date
that is ten (10) business days prior to the meeting or any adjournment or postponement thereof, and such update and supplement shall be
delivered to, or mailed and received by, the Secretary of the Corporation at the principal executive offices of the Corporation not later
than five (5) business days after the record date for the meeting (in the case of the update and supplement required to be made as of
the record date), and not later than eight (8) business days prior to the date for the meeting, or if the meeting is adjourned or postponed,
on the first practicable date after any adjournment or postponement thereof (in the case of the update and supplement required to be made
as of ten (10) business days prior to the meeting or any adjournment or postponement thereof)&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.25pt 0pt 5pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>the proponent stockholder must disclose to the Corporation, as part of the advance notice, its name and address as they appear
on the Corporation&rsquo;s books and of any beneficial owner, if any, and their respective affiliates and associates or others acting
in concert therewith&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.25pt 0pt 5pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.25pt 0pt 5pt; text-indent: 80.05pt"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.25pt 0pt 5pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif">  </FONT>the
proponent stockholder must disclose to the Corporation, as part of the advance notice, (a) the class or series and number of shares
of capital stock or other securities of the Corporation which are, directly or indirectly, owned of record or beneficially (within
the meaning of Rule 13d-3 under the Securities Exchange Act of 1934, as amended) by such proponent stockholder, (b) any option,
warrant, convertible security, stock appreciation right, or similar right with an exercise or conversion privilege or a settlement
payment or mechanism at a price related to any shares of capital stock or other securities of the Corporation or with a price or
value derived in whole or in part from the price or value of any shares of capital stock or other securities of the Corporation or
any derivative, synthetic, hedging, swap or similar transaction or arrangement having characteristics of a long or short position or
ownership interest in any shares of capital stock or other securities of the Corporation, whether or not any such instrument or
right shall be subject to settlement in the underlying shares of capital stock or other securities of the Corporation or otherwise,
and any other direct or indirect opportunity to profit or share in any profit derived from any increase or decrease in the price or
value of shares of capital stock or other securities of the Corporation directly or indirectly owned beneficially by such proponent
stockholder, (c) a reasonably detailed description of any proxy, agreement, arrangement, understanding or relationship pursuant to
which such proponent stockholder has given or received a right to vote, directly or indirectly, any shares of capital stock or other
securities of the Corporation, (d) a reasonably detailed description of any agreement, arrangement, understanding or relationship,
including any repurchase or similar so-called &ldquo;stock borrowing&rdquo; agreement or arrangement, which such proponent
stockholder has engaged in or is a party to, directly or indirectly, the purpose or effect of which is to mitigate loss to, reduce
the economic risk of shares of capital stock or other securities of the Corporation by, manage the risk of share price changes for,
or increase or decrease the voting power of, such proponent stockholder with respect to shares of capital stock or other securities
of the Corporation, or which provides, directly or indirectly, the opportunity to profit from any increase or decrease in the price
or value of the shares of capital stock or other securities of the Corporation, (e) any rights to dividends or other distributions
on the shares of any class or series of capital stock of the Corporation, directly or indirectly, owned beneficially by the
proponent stockholder that are separated or separable from the underlying shares of the Corporation, (f) any performance-related
fees (other than an asset based fee) that the proponent stockholder, directly or indirectly, is entitled to based on any increase or
decrease in the value of shares of any class or series of capital stock of the Corporation or any interests described in clause (d),
(g) any proportionate interest in any security of the Corporation or derivative instruments held, directly or indirectly, by a
general or limited partnership or limited liability company or similar entity in which a proponent stockholder is a general partner
or, directly or indirectly, beneficially owns any interest in a general partner or is the manager or managing member or, directly or
indirectly, beneficially owns any interest in the manager or managing member of a limited liability company or similar entity, (h)
any Short Interest held by a proponent stockholder presently or within the last 12 months in any security of the Corporation (for
purposes of these By-Laws, a person shall be deemed to have a &ldquo;Short Interest&rdquo; in a security if such person, directly or
indirectly, though any contract, arrangement, understanding, relationship or otherwise, has the opportunity to profit or share in
any profit derived from any decrease in the value of the subject security), (i) any direct or indirect legal, economic or financial
interest (including Short Interest) of a proponent stockholder in the outcome of any (1) vote to be taken at any annual or special
meeting of stockholders of the Corporation or (2) any meeting of stockholders of any other entity with respect to any matter that is
related, directly or indirectly, to any business proposed by any proponent stockholder under Article IV, (j) any direct or indirect
legal, economic or financial interest (including Short Interest) in any principal competitor of the Corporation held by a proponent
stockholder, (k) any material pending or threatened action, suit or proceeding (whether civil, criminal, investigative,
administrative or otherwise) in which a proponent stockholder is, or is reasonably expected to be made, a party or material
participant involving the Corporation or any of its officers, directors or employees, or any affiliate of the Corporation, or any
officer, director or employee of such affiliate, and (l) any other information relating to such stockholder and beneficial owner, if
any, required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies
for the proposal pursuant to and in accordance with Section 14(a) of the Securities Exchange Act of 1934, as amended and the rules
and regulations promulgated thereunder<FONT STYLE="font-size: 10pt">&#894;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.25pt 0pt 5pt; text-indent: 80.05pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>the proponent stockholder must also disclose to the Corporation, as part of the advance notice, all stock ownership information
required by the immediately preceding clause (iv) with respect to (a) the beneficial owner or beneficial owners of capital stock of the
Corporation, if different, on whose behalf the business proposed to be brought before the annual meeting is being brought, (b) any affiliate
or associate (each within the meaning of Rule 12b-2 under the Securities Exchange Act of 1934, as amended) of the proponent stockholder
or any such beneficial owner, (c) any stockholder or stockholder group with whom the proponent stockholder is acting in concert with,
whether or not such persons constitute a filing group for purposes of Schedule 13D, and (d) any other person or persons (including their
names) in connection with the proposal of such business&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.25pt 0pt 5pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>the proponent stockholder must represent to the Corporation, as part of the advance notice, whether the proponent intends individually
or as part of a group, to (x) deliver a proxy statement and/or form of proxy to holders of at least the percentage of the Corporation&rsquo;s
outstanding capital stock required to approve or adopt the proposal, and/or (y) to otherwise solicit proxies in support of such proposal&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.25pt 0pt 5pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.25pt 0pt 5pt; text-indent: 80.05pt"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.25pt 0pt 5pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(vii) the proponent
stockholder must disclose to the Corporation, as part of its advance notice: (a) a reasonably brief description of the business
desired to be brought before the meeting, the reasons for conducting such business at the meeting and any material interest of such
stockholder and beneficial owner, if any, in such business, (b) the text of the proposal or business (including the text of any
resolutions proposed for consideration and in the event that such business includes a proposal to amend the By-Laws of the
Corporation, the language of the proposed amendment), and (c) a reasonably detailed description of all agreements, arrangements and
understandings between such proponent and the beneficial owner, if any, and any other person or persons (including their names) in
connection with the proposal of such business by such stockholder<FONT STYLE="font-size: 10pt">&#894;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.25pt 0pt 5pt; text-indent: 80.05pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT>the
proponent stockholder must provide a representation to the Corporation, as part of its advance notice, that the proponent
stockholder is a holder of record of capital stock of the Corporation entitled to vote at the meeting, will continue to be a
stockholder of record of the Corporation entitled to vote at such meeting through the date of such meeting and intends to appear in
person or by proxy at the meeting to propose the stockholder business specified in the notice&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(ix)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>the proponent stockholder must provide, as part of its advance notice, a certification by the proponent stockholder of the accuracy
of the information set forth in the advance notice&#894; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>the proponent stockholder must provide, as part of its advance notice, the names and addresses of other stockholders (including
beneficial and record owners) known by the proponent stockholder to support the stockholder business to be proposed by the proponent stockholder
and, to the extent known, the class or series and number of all shares of capital stock of the Corporation owned beneficially or of record
by such other stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.35pt">3.<FONT STYLE="font-family: Times New Roman, Times, Serif"> &nbsp;
</FONT></FONT>In addition to the provisions of Section 2 of this Article IV, a stockholder shall also comply with all applicable requirements
of state law and all applicable requirements of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder,
with respect to the matters set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.6pt 0pt 5pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.35pt">4.<FONT STYLE="font-family: Times New Roman, Times, Serif"> &nbsp;
</FONT></FONT>Nothing in these By-laws shall be deemed to affect any rights of stockholders to request the inclusion of proposals in the
Corporation&rsquo;s proxy statement pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended. Subject to Rule 14a-8
and Rule 14a-19 under the Securities Exchange Act of 1934, as amended, nothing in these By-laws shall be construed to permit any stockholder,
or give any stockholder the right, to include or have disseminated or described in the Corporation&rsquo;s proxy statement any nomination
of director or directors or any other business proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.6pt 0pt 5pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.35pt">5.<FONT STYLE="font-family: Times New Roman, Times, Serif"> &nbsp;
</FONT></FONT>Except as otherwise expressly provided in any applicable rule or regulation promulgated under the Securities Exchange Act
of 1934, as amended, only such business (other than the election of directors as set forth in Article V) shall be conducted at an annual
meeting of stockholders as shall have been brought before the meeting in accordance with the procedures of this Article IV. Except as
otherwise provided by law, the chairperson of the meeting shall have the power and duty (i) to determine whether any business proposed
to be brought before the meeting was proposed in accordance with the provisions of this Article IV (including whether the proponent stockholder
solicited (or are part of a group which solicited) or did not so solicit, as the case may be, proxies or votes in support of the proponent
stockholder&rsquo;s proposal in compliance with the proponent stockholder&rsquo;s representation as required by clause (vi) of Section
2 of Article IV) and (ii) if any proposed business was not proposed in compliance with Article IV, to declare that such proposed business
shall not be transacted. Notwithstanding the foregoing provisions of this Article IV, unless otherwise required by law, if the proponent
stockholder (or a qualified representative of the proponent stockholder) does not appear at the annual meeting of stockholders of the
Corporation to present the proposed business, such proposed business shall not be transacted, notwithstanding that proxies in respect
of such vote may have been received by the Corporation. For purposes of this Section 5 of Article IV, to be considered a qualified representative
of the proponent stockholder, a person must be a duly authorized officer, manager or partner of such proponent stockholder or must be
authorized by a writing executed by such proponent stockholder or an electronic transmission delivered by such proponent stockholder to
act for such proponent stockholder as proxy at the meeting of stockholders and such person must produce such writing or electronic transmission,
or a reliable reproduction of the writing or electronic transmission, at the meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.6pt 0pt 5pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 2.85pt 0pt 2.55pt; text-align: center"><FONT STYLE="letter-spacing: -0.35pt">ARTICLE</FONT>
<FONT STYLE="letter-spacing: -0.3pt">V</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.55pt; text-align: center"><FONT STYLE="letter-spacing: -0.25pt">STOCKHOLDER
</FONT> <FONT STYLE="letter-spacing: -0.2pt">DIRECTOR NOMINATIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.55pt; text-align: center"><FONT STYLE="letter-spacing: -0.2pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">1. At an annual meeting of
stockholders, only such nominations of persons for the election of directors shall be conducted as shall have been properly brought
before the meeting. To be properly brought before an annual meeting of stockholders, nominations of persons for election to the
Board of Directors must be: (i) specified in the notice of the meeting (or any supplement thereto) given by or at the direction of
the Board of Directors or any committee thereof, (ii) otherwise properly brought before the meeting by or at the direction of the
Board of Directors or any committee thereof, or (iii) otherwise properly brought before an annual meeting by a stockholder (a) who
is a stockholder of record of the Corporation at the time the notice provided for in this Article V is delivered to, or mailed and
received by, the Secretary of the Corporation, on the record date for the determination of stockholders of the Corporation entitled
to vote at the meeting, and at the time of the meeting, (b) who is entitled to vote at the meeting and (c) complies with the notice
procedures set forth in this Article V.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 5pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 5pt; text-indent: 60.6pt"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 5pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Notwithstanding anything in these By-laws to the contrary, for the nomination of persons for election to the Board of Directors
to be properly brought before the annual meeting by a stockholder, the stockholder or stockholders of record intending to propose such
nominations must deliver a timely and proper advance notice to the Secretary of the Corporation that complies with the following requirements:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>to be timely, the advance notice must be in writing and must be delivered to, or mailed and received by, the Secretary of the Corporation
at the principal executive offices of the Corporation no earlier than one hundred and twenty (120) days, and no later than ninety (90)
days, prior to the first anniversary date of the prior year&rsquo;s annual meeting&#894; provided, however, that in the event that the
annual meeting is called for a date that is more than thirty (30) days before or more than sixty (60) days after such anniversary date
(or with respect to any other annual meeting of stockholders, including in the event that no annual meeting was held in the previous year),
notice by the proponent stockholder in order to be timely must be so delivered, or mailed and received by, the Secretary of the Corporation
at the principal executive offices of the Corporation, not earlier than the close of business on the 120th day prior to the annual meeting
and not later than the close of business on the later of the 90th day prior to the date of such annual meeting or, if the first Public
Announcement of the date of such annual meeting is less than one hundred (100) days prior to the date of such annual meeting, the 10th
day following the day on which Public Announcement of the date of such meeting is first made by the Corporation. In no event shall any
adjournment or postponement of an annual meeting, or the Public Announcement thereof, commence a new time period (or extend any notice
time period) for the giving of a stockholder&rsquo;s notice as described above&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>in addition, to be timely, a stockholder&rsquo;s notice shall further be updated and supplemented, if necessary, so that the information
provided or required to be provided in such notice shall be true and correct as of each of the record date for the meeting and the date
that is ten (10) business days prior to the meeting or any adjournment or postponement thereof, and such update and supplement shall be
delivered to, or mailed and received by, the Secretary of the Corporation at the principal executive offices of the Corporation not later
than five (5) business days after the record date for the meeting (in the case of the update and supplement required to be made as of
the record date), and not later than eight (8) business days prior to the date for the meeting, or if the meeting is adjourned or postponed,
on the first practicable date after any adjournment or postponement thereof (in the case of the update and supplement required to be made
as of ten (10) business days prior to the meeting or any adjournment or postponement thereof)&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>in the event that the number of directors to be elected to the Board of Directors is increased by the Board of Directors, and there
is no Public Announcement by the Corporation naming all of the nominees for director or specifying the size of the increased Board of
Directors at least one hundred (100) days prior to the first anniversary of the preceding year&rsquo;s annual meeting, a stockholder&rsquo;s
notice required by Section 2 of this Article V shall also be considered timely, but only with respect to nominees for any new positions
created by such increase, if it shall be delivered to, or mailed and received by, the Secretary of the Corporation at the principal executive
offices of the Corporation not later than the close of business on the 10th day following the day on which such Public Announcement is
first made by the Corporation&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>the proponent stockholder must disclose to the Corporation, as part of the advance notice, its name and address as they appear
on the Corporation&rsquo;s books and of any beneficial owner, if any, and their respective affiliates and associates or others acting
in concert therewith&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(v) the proponent
stockholder must disclose to the Corporation, as part of the advance notice, (a) the class or series and number of shares of capital
stock or other securities of the Corporation which are, directly or indirectly, owned of record or beneficially (within the meaning
of Rule 13d-3 under the Securities Exchange Act of 1934, as amended) by such proponent stockholder, (b) any option, warrant,
convertible security, stock appreciation right, or similar right with an exercise or conversion privilege or a settlement payment or
mechanism at a price related to any shares of capital stock or other securities of the Corporation or with a price or value derived
in whole or in part from the price or value of any shares of capital stock or other securities of the Corporation or any derivative,
synthetic, hedging, swap or similar transaction or arrangement having characteristics of a long or short position or ownership
interest in any shares of capital stock or other securities of the Corporation, whether or not any such instrument or right shall be
subject to settlement in the underlying shares of capital stock or other securities of the Corporation or otherwise, and any other
direct or indirect opportunity to profit or share in any profit derived from any increase or decrease in the price or value of
shares of capital stock or other securities of the Corporation directly or indirectly owned beneficially by such proponent
stockholder, (c) a reasonably detailed description of any proxy, agreement, arrangement, understanding or relationship pursuant to
which such proponent stockholder has given or received a right to vote, directly or indirectly, any shares of capital stock or other
securities of the Corporation, (d) a reasonably detailed description of any agreement, arrangement, understanding or relationship,
including any repurchase or similar so-called &ldquo;stock borrowing&rdquo; agreement or arrangement, which such proponent
stockholder has engaged in or is a party to, directly or indirectly, the purpose or effect of which is to mitigate loss to, reduce
the economic risk of shares of capital stock or other securities of the Corporation by, manage the risk of share price changes for,
or increase or decrease the voting power of, such proponent stockholder with respect to shares of capital stock or other securities
of the Corporation, or which provides, directly or indirectly, the opportunity to profit from any increase or decrease in the price
or value of the shares of capital stock or other securities of the Corporation, (e) any rights to dividends or other distributions
on the shares of any class or series of capital stock of the Corporation, directly or indirectly, owned beneficially by the
proponent stockholder that are separated or separable from the underlying shares of the Corporation, (f) any performance-related
fees (other than an asset based fee) that the proponent stockholder, directly or indirectly, is entitled to based on any increase or
decrease in the value of shares of any class or series of capital stock of the Corporation or any interests described in clause (d),
(g) any proportionate interest in any security of the Corporation or derivative instruments held, directly or indirectly, by a
general or limited partnership or limited liability company or similar entity in which a proponent stockholder is a general partner
or, directly or indirectly, beneficially owns any interest in a general partner or is the manager or managing member or, directly or
indirectly, beneficially owns any interest in the manager or managing member of a limited liability company or similar entity, (h)
any Short Interest held by a proponent stockholder presently or within the last 12 months in any security of the Corporation, (i)
any direct or indirect legal, economic or financial interest (including Short Interest) of a proponent stockholder in the outcome of
any (1) vote to be taken at any annual or special meeting of stockholders of the Corporation or (2) any meeting of stockholders of
any other entity with respect to any matter that is related, directly or indirectly, to any nomination proposed by any proponent
stockholder under Article V, (j) any direct or indirect legal, economic or financial interest (including Short Interest) in any
principal competitor of the Corporation held by a proponent stockholder, (k) any material pending or threatened action, suit or
proceeding (whether civil, criminal, investigative, administrative or otherwise) in which a proponent stockholder is, or is
reasonably expected to be made, a party or material participant involving the Corporation or any of its officers, directors or
employees, or any affiliate of the Corporation, or any officer, director or employee of such affiliate, and (l) any other
information relating to such stockholder and beneficial owner, if any, required to be disclosed in a proxy statement or other
filings required to be made in connection with solicitations of proxies for the election of directors in an election contest
pursuant to and in accordance with Section 14(a) of the Securities Exchange Act of 1934, as amended and the rules and regulations
promulgated thereunder (collectively, the information in this clause (v), the &ldquo;Stockholder Information<FONT STYLE="font-size: 10pt">&rdquo;)&#894;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT> the proponent stockholder must also disclose to the Corporation, as part of the advance notice, all stock ownership information
required by the immediately preceding clause (v) with respect to (a) the beneficial owner or beneficial owners of capital stock of the
Corporation, if different, on whose behalf the nomination proposed to be brought before the annual meeting is made, (b) any affiliate
or associate (each within the meaning of Rule 12b-2 under the Securities Exchange Act of 1934, as amended) of the proponent stockholder
or any such beneficial owner, and, (c) any stockholder or stockholder group with whom the proponent stockholder is acting in concert with,
whether or not such persons constitute a filing group for purposes of Schedule 13D, and (d) any other person or persons (including their
names) in connection with the proposal of such nomination&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.25pt 0pt 5pt; text-indent: 80.05pt">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.25pt 0pt 5pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT> the proponent stockholder must represent to the Corporation, as part of the advance notice, whether the proponent or any of its
respective affiliates, associates or others acting in concert therewith intends individually or as part of a group, to (a) deliver a proxy
statement and/or form of proxy to holders of at least the percentage of the Corporation&rsquo;s outstanding capital stock required to
elect the nominee and/or (b) to otherwise solicit proxies in support of such nomination, including to solicit proxies in support of director
nominees other than the Corporation&rsquo;s nominees in accordance with Rule 14a-19 under the Securities Exchange Act of 1934, as amended&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.25pt 0pt 5pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT>the proponent stockholder must disclose to the Corporation, as part of the advance notice, as to each person whom the proponent
stockholder proposes to nominate for election as a director (a) all information about the proposed nominees that would be required to
be to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for the election
of directors in a contested election pursuant to Section 14 of the Securities Exchange Act of 1934, as amended, and the rules and regulations
promulgated thereunder (including such person&rsquo;s written consent to being named in the proxy statement, including the Corporation&rsquo;s
proxy statement, as a nominee of the proponent stockholder and to serving as a director if elected), (b) a complete and accurate description
of all direct and indirect compensation and other material monetary agreements, arrangements and understandings (whether written or oral)
during the past three years, and any other material relationships, between or among such stockholder and beneficial owner, if any, and
their respective affiliates and associates, or others acting in concert therewith, on the one hand, and each proposed nominee, and his
or her respective affiliates and associates, or others acting in concert therewith, on the other hand, including, without limitation all
information that would be required to be disclosed pursuant to Rule 404 promulgated under Regulation S-K if the stockholder making the
nomination and any beneficial owner on whose behalf the nomination is made, if any, or any affiliate or associate thereof or person acting
in concert therewith, were the &ldquo;registrant&rdquo; for purposes of such rule and such proposed nominee were a director or executive
officer of such registrant, (c) a completed and signed questionnaire, representation and agreement and any and all other information required
by Section 4 of Article V, and (d) the Stockholder Information for such person and any member of the immediate family of such person,
or any affiliate or associate of such person, or any person acting in concert therewith&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(ix)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>the proponent stockholder must provide a representation to the Corporation, as part of its advance notice, that the proponent stockholder
is a holder of record of capital stock of the Corporation entitled to vote at the meeting, will continue to be a stockholder of record
of the Corporation entitled to vote at such meeting through the date of such meeting and intends to appear in person or by proxy at the
meeting to propose the nomination(s) specified in the notice&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.25pt 0pt 5pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>the proponent stockholder must provide, as part of its advance notice, a certification by the proponent stockholder of the accuracy
of the information set forth in the advance notice&#894; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.25pt 0pt 5pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(xi)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>the proponent stockholder must provide, as part of its advance notice, the names and addresses of other stockholders (including
beneficial and record owners) known by the proponent stockholder to support the nomination(s) made by the proponent stockholder and, to
the extent known, the class or series and number of all shares of capital stock of the Corporation owned beneficially or of record by
such other stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8.25pt 0pt 5pt; text-indent: 80.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">3. Nominations of persons
for election to the Board of Directors may be made at a special meeting of stockholders at which directors are to be elected
pursuant to the Corporation&rsquo;s notice of meeting (i) by or at the direction of the Board of Directors or any committee thereof
or (ii) provided that the Board of Directors has determined that directors shall be elected at such meeting, by any stockholder of
the Corporation (a) who is a stockholder of record of the Corporation at the time the notice provided for in this Article V is
delivered to, or mailed and received by, the Secretary of the Corporation, on the record date for the determination of stockholders
of the Corporation entitled to vote at the meeting, and at the time of the meeting, (b) who is entitled to vote at the meeting and
(c) complies with the notice procedures set forth in this Article V. In the event the Corporation calls a special meeting of
stockholders for the purpose of electing one (1) or more directors to the Board of Directors, any such proponent stockholder
entitled to vote in such election of directors may nominate a person or persons (as the case may be) for election to such
position(s) as specified in the Corporation&rsquo;s notice of meeting, if the notice required by Section 2 of Article V shall be
delivered to, or mailed and received by, the Secretary of the Corporation at the principal executive offices of the Corporation no
earlier than one hundred and twenty (120) days prior to the special meeting, and no later than ninety (90) days prior to the special
meeting, or the tenth (10th) day following the day on which the Corporation first makes a public announcement of the date of the
special meeting at which directors are to be elected. In no event shall the public announcement of an adjournment or postponement of
a special meeting commence a new time period (or extend any time period) for the giving of a stockholder&rsquo;s notice as described
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>In addition to the requirements set forth elsewhere in these By-Laws, to be eligible to be a nominee for election or re-election
as a director of the Corporation, such proposed nominee or a person on such proposed nominee&rsquo;s behalf must deliver (with respect
to a nomination made by a proponent pursuant to Section 2 of Article V, in accordance with the time periods for delivery of timely notice
under Section 2 of Article V), to the Secretary of the Corporation at the principal executive offices of the Corporation a completed and
signed questionnaire with respect to the background and qualifications of such proposed nominee and the background of any other person
or entity on whose behalf the nomination is being made (which questionnaire shall be provided by the Secretary of the Corporation upon
written request of any stockholder of record identified by name within <STRIKE STYLE="color: Red">five</STRIKE><U STYLE="color: rgb(50,101,255)">ten</U> business days of such written request)
and a written representation and agreement (in the form provided by the Secretary of the Corporation upon written request of any stockholder
of record identified by name within <STRIKE STYLE="color: Red">five</STRIKE><U STYLE="color: rgb(50,101,255)">ten</U> business days of such written request) that such proposed nominee
(i) is not and will not become a party to (a) any agreement, arrangement or understanding with, and has not given any commitment or assurance
to, any person or entity as to how such proposed nominee, if elected as a director of the Corporation, will act or vote on any issue or
question (a &ldquo;Voting Commitment&rdquo;) that has not been disclosed to the Corporation or (b) any Voting Commitment that could limit
or interfere with such proposed nominee&rsquo;s fiduciary duties under applicable law, (ii) is not and will not become a party to any
agreement, arrangement or understanding with any person or entity other than the Corporation with respect to any direct or indirect compensation,
reimbursement or indemnification in connection with service or action as a director that has not been disclosed to the Corporation, and
(iii) would be in compliance, if elected as a director of the Corporation, and will comply with, all applicable publicly disclosed corporate
governance, code of conduct and ethics, conflict of interest, confidentiality, corporate opportunities, trading and any other policies
and guidelines of the Corporation applicable to directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Corporation may also require, as a condition to any such nomination being deemed properly brought before an annual or special
meeting, any proponent stockholder or proposed nominee to furnish such other information as may reasonably be required by the Corporation
to determine the eligibility of such proposed nominee to serve as an independent director of the Corporation or that could be material
to a reasonable stockholder&rsquo;s understanding of the independence, or lack thereof, of such nominee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 5pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">6.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>In addition, if the proponent stockholder has provided notice pursuant to Rule 14a-19(b) of the Securities Exchange Act of 1934,
as amended, the proponent stockholder shall deliver to the Corporation no later than ten (10) days prior to the date of the meeting or
any adjournment or postponement thereof reasonable evidence that it has complied with the requirements of Rule 14a-19 of the Securities
Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 5pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">7. Compliance with the
provisions of this Article V is the sole and exclusive method for stockholders to nominate candidates for election to the Board of
Directors at an annual or special meeting of stockholders. No person shall be eligible for election as a director of the Corporation
at an annual or special meeting of stockholders unless nominated in accordance with the procedures set forth in this Article V. The
number of nominees that a proponent stockholder may nominate for election at an annual or special meeting (or in the case of a
proponent stockholder giving the notice on behalf of a beneficial owner, the number of nominees a proponent stockholder may nominate
for election at the annual or special meeting on behalf of such beneficial owner) shall not exceed the number of directors to be
elected at such annual or special meeting. For the avoidance of doubt, a stockholder shall not be entitled to make additional or
substitute nominations at an annual or special meeting following the expiration of the time periods set forth in these By-Laws.
Unless otherwise required by law, if any proponent stockholder (i) provides notice pursuant to Rule 14a-19(b) under the Securities
Exchange Act of 1934, as amended, and (ii) subsequently fails to comply with any requirements of Rule 14a-19 of the Securities
Exchange Act of 1934, as amended, or any other rules or regulations thereunder, then the Corporation shall disregard any proxies or
votes solicited for such nominees and such nominations shall be disregarded. Except as otherwise provided by law or herein, the
chairperson of the meeting shall have the power and duty (i) to determine whether a nomination was made in accordance with the
provisions of this Article V (including whether the proponent stockholder or any of its respective affiliates, associates or others
acting in concert therewith solicited (or are part of a group which solicited) or did not so solicit, as the case may be, proxies or
votes in support of the proponent stockholder&rsquo;s nominee in compliance with the proponent stockholder&rsquo;s representation as
required by clause (vii) of Section 2 of Article V) and (ii) if any proposed nomination was not made in compliance with Article V,
to declare that such nomination shall be disregarded. Notwithstanding the foregoing provisions of Article V, unless otherwise
required by law, if the proponent stockholder (or a qualified representative of the proponent stockholder) does not appear at the
annual or special meeting of stockholders of the Corporation to present a nomination, such nomination shall be disregarded,
notwithstanding that proxies in respect of such vote may have been received by the Corporation. For purposes of this Section 7 of
Article V, to be considered a qualified representative of the proponent stockholder, a person must be a duly authorized officer,
manager or partner of such proponent stockholder or must be authorized by a writing executed by such proponent stockholder or an
electronic transmission delivered by such proponent stockholder to act for such proponent stockholder as proxy at the meeting of
stockholders and such person must produce such writing or electronic transmission, or a reliable reproduction of the writing or
electronic transmission, at the meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 60.6pt"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">8.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>In addition to the provisions of this Article V, a stockholder shall also comply with all applicable requirements of state law
and all applicable requirements of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder, with respect
to the matters set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">9.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>For purposes of these By-laws, &ldquo;Public Announcement&rdquo; shall mean disclosure in a press release reported by a national
news service or in a document publicly filed by the Corporation with the Securities and Exchange Commission pursuant to Section 13, 14
or 15(d) of the Securities Exchange Act of 1934, as amended and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.5pt">ARTICLE</FONT>
<FONT STYLE="letter-spacing: -0.45pt">VI</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">DIRECTORS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The business and affairs of the Corporation shall be managed under the direction of a Board of Directors, which may exercise all
such powers and authority for and on behalf of the Corporation as shall be permitted by law, the Certificate of Incorporation or these
By-laws. Each of the directors shall hold office until the next annual meeting of stockholders and until his or her successor has been
elected and qualified or until his or her earlier death, disqualification, resignation or removal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 58.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The <FONT STYLE="letter-spacing: -0.45pt">Board</FONT> of Directors is empowered to appoint a Chairman of the Board of Directors.
The Chairman shall act as chairman of all meetings of the Board of Directors and <FONT STYLE="letter-spacing: -0.2pt"><U STYLE="color: rgb(50,101,255)">as the presiding
person </U></FONT>at all special and annual meetings of stockholders, <U STYLE="color: rgb(50,101,255)">unless the Board of Directors shall appoint a different individual
as chairman of any meeting of the Board of Directors or as the presiding person at any special or annual meeting of stockholders,</U>
and <FONT STYLE="letter-spacing: -0.15pt"><U STYLE="color: rgb(50,101,255)">the chairman or presiding person </U></FONT>shall have control over the agenda of <FONT STYLE="letter-spacing: -0.1pt"><U STYLE="color: rgb(50,101,255)">any</U></FONT>
such meetings, all in accordance with the provisions of these By-laws and the Certificate of Incorporation. The Chairman shall perform
such other duties as may from time to time be assigned to him by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 58.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The <FONT STYLE="letter-spacing: -0.45pt">Board</FONT> of Directors may hold their meetings within or outside of the State of Delaware,
at such place or places as it may from time to time determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 58.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The <FONT STYLE="letter-spacing: -0.45pt">number </FONT>of directors comprising the Board of Directors shall be such number as
may be from time to time fixed <U STYLE="color: rgb(50,101,255)">exclusively</U> by resolution of the Board of Directors.<STRIKE STYLE="color: Red"> </STRIKE> In case of any
increase<STRIKE STYLE="color: Red">,</STRIKE> <U STYLE="color: rgb(50,101,255)">in the number of directors, a majority of the remaining members of</U> the Board of Directors<U STYLE="color: rgb(50,101,255)">, although
such majority is less than a quorum,</U> shall have <U STYLE="color: rgb(50,101,255)">the sole and exclusive </U>power <U STYLE="color: rgb(50,101,255)">and authority </U>to elect each additional
director <U STYLE="color: rgb(50,101,255)">to fill any newly created directorship,</U> to hold office until the next annual meeting of stockholders and until his or
her successor is elected and qualified or his or her earlier death, disqualification, resignation or removal.<STRIKE STYLE="color: Red"> Any decrease
in the number of directors shall take effect at the time of such action by the Board of Directors only to the extent that vacancies then
exist; to the extent that such decrease exceeds the number of such vacancies, the decrease shall not become effective, except as further
vacancies may thereafter occur, until the time of and in connection with the election of directors at the next succeeding annual meeting
of the stockholders.</STRIKE> No decrease in the number of directors shall shorten the term of any incumbent director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 58.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 58.5pt"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 58.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">5.
If <FONT STYLE="color: Red"><STRIKE>the office of </STRIKE></FONT>any <FONT STYLE="color: Red"><STRIKE>director</STRIKE></FONT><FONT STYLE="color: rgb(50,101,255)"><U>directorship
</U></FONT>becomes vacant, by reason of death, resignation, disqualification<FONT STYLE="color: rgb(50,101,255)"><U>, removal</U></FONT>
or otherwise, a majority of the directors then in office, although less than a quorum, <FONT STYLE="color: Red"><STRIKE>may</STRIKE></FONT><FONT STYLE="color: rgb(50,101,255)"><U>shall
have the sole and exclusive authority to</U></FONT> <FONT STYLE="font-size: 10pt">fill the vacancy by electing a successor who shall hold
office <FONT STYLE="letter-spacing: -0.45pt">until</FONT> the next annual meeting of stockholders and until his or her successor is elected
and qualified or his or her earlier <FONT STYLE="color: rgb(50,101,255)"><U>death, </U></FONT>resignation<FONT STYLE="color: rgb(50,101,255)"><U>,
disqualification</U></FONT> or removal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">6.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Any <FONT STYLE="letter-spacing: -0.45pt">director</FONT> may resign at any time by giving <STRIKE STYLE="color: Red">written </STRIKE>notice of his
or her resignation to the <STRIKE STYLE="color: Red">Board of Directors. </STRIKE><U STYLE="color: rgb(50,101,255)">Corporation in writing or by electronic transmission. </U>Any
such resignation shall take effect upon receipt thereof by the <STRIKE STYLE="color: Red">Board of Directors</STRIKE><U STYLE="color: rgb(50,101,255)">Corporation</U>, or at such later
<U STYLE="color: rgb(50,101,255)">time or </U>date as may be specified therein.<STRIKE STYLE="color: Red"> Any such notice to the Board of Directors shall be addressed to it
in care of the Secretary.</STRIKE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 58.5pt"><STRIKE STYLE="text-decoration: none; color: Red">&nbsp;</STRIKE></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.5pt">ARTICLE</FONT>
<FONT STYLE="letter-spacing: -0.45pt">VII</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.15pt">COMMITTEES
OF</FONT> <FONT STYLE="letter-spacing: -0.1pt">DIRECTORS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Board of Directors may designate an Executive Committee and one or more other committees, each such committee to consist of
one or more directors of the Corporation. The Executive Committee shall have and may exercise all the powers and authority of the Board
of Directors in the management of the business and affairs of the Corporation (except as otherwise expressly limited by statute), including
the power and authority to declare dividends and to authorize the issuance of stock, and may authorize the seal of the Corporation to
be affixed to all papers which may require it. Each such committee shall have such of the powers and authority of the Board of Directors
as may be provided from time to time in resolutions adopted by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The requirements with respect to the manner in which the Executive Committee and each such other committee shall hold meetings
and take actions shall be set forth in the resolutions of the Board of Directors designating the Executive Committee or such other committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.5pt">ARTICLE</FONT>
<FONT STYLE="letter-spacing: -0.45pt">VIII</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><STRIKE STYLE="text-decoration: none; color: Red">&nbsp;</STRIKE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><STRIKE STYLE="color: Red">COMPENSATION OF DIRECTORS</STRIKE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><STRIKE STYLE="text-decoration: none; color: Red">&nbsp;</STRIKE></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><STRIKE STYLE="color: Red">The directors shall receive such compensation for their services
as may be authorized by resolution of the Board of Directors, which compensation may be in either cash or equity, or a combination thereof,
and may include an annual fee, a fixed sum for attendance at regular or special meetings of the Board of Directors or any committee thereof
and reimbursement of expenses reasonably incurred in attending such meetings. Nothing herein contained shall be construed to
preclude any director from serving the Corporation in any other capacity and receiving compensation therefor.</STRIKE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><STRIKE STYLE="text-decoration: none; color: Red">&nbsp;</STRIKE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-weight: normal; letter-spacing: -0.35pt"><STRIKE STYLE="color: Green">ARTICLE</STRIKE></FONT><STRIKE STYLE="color: Green">
<FONT STYLE="font-weight: normal; letter-spacing: -0.55pt">I</FONT></STRIKE><STRIKE STYLE="color: Green"><FONT STYLE="font-weight: normal; letter-spacing: -0.3pt">X</FONT></STRIKE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.1pt">MEETINGS</FONT>
<FONT STYLE="letter-spacing: -0.05pt">OF DIRECTORS&#894; ACTION WITHOUT A MEETING</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.05pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Regular meetings of the Board of Directors may be held without notice at such time and place, either within or without the State
of Delaware, as may be determined from time to time by resolution of the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Special meetings of the Board of Directors shall be held whenever called by the President of the Corporation or the majority of
the <STRIKE STYLE="color: Red">Board of Directors</STRIKE><U STYLE="color: rgb(50,101,255)">directors then in office</U> on at least 24 hours&rsquo; notice to each director.<STRIKE STYLE="color: Red"> </STRIKE>
Except as may be otherwise specifically provided by statute, by the Certificate of Incorporation or by these By-laws, the purpose or purposes
of any such special meeting need not be stated in such notice, although the time and place of the meeting shall be stated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>At all meetings of the Board of Directors, the presence in person of a majority of the total number of directors shall be necessary
and sufficient to constitute a quorum for the transaction of business, and, except as otherwise provided by statute, by the Certificate
of Incorporation or by these By-laws, if a quorum shall be present the act of a majority of the directors present shall be the act of
the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 60.6pt"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Any action required or permitted to be taken at any meeting of the Board of Directors or of any committee thereof may be taken
without a meeting if all the members of the Board of Directors or such committee, as the case may be, consent thereto in writing or by
electronic transmission and <U STYLE="color: rgb(50,101,255)">any consent may be documented, signed and delivered in any manner permitted by Section 116 of the General
Corporation Law of the State of Delaware. After an action is taken, </U>the consent or consents or electronic transmissions <STRIKE STYLE="color: Red">are</STRIKE><U STYLE="color: rgb(50,101,255)">shall
be</U> filed with the minutes of proceedings of the Board of Directors or committee, in the same paper or electronic form as the minutes
are maintained.<STRIKE STYLE="color: Red"> </STRIKE> Any director may participate in a meeting of the Board of Directors, or any committee designated
by the Board of Directors, by means of a conference telephone or <STRIKE STYLE="color: Red">similar</STRIKE><U STYLE="color: rgb(50,101,255)">other</U> communications equipment by means
of which all persons participating in the meeting can hear each other, and participation in a meeting pursuant to this sentence shall
constitute presence in person at such meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.35pt"><U STYLE="color: Green">ARTICLE</U></FONT><U STYLE="color: Green">
<FONT STYLE="letter-spacing: -0.55pt">I</FONT><FONT STYLE="letter-spacing: -0.3pt">X</FONT></U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-weight: normal; letter-spacing: -0.5pt"><STRIKE STYLE="color: Green">ARTICLE</STRIKE></FONT><STRIKE STYLE="color: Green">
<FONT STYLE="font-weight: normal; letter-spacing: -0.45pt">X</FONT></STRIKE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.2pt">OFFICERS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.2pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">1. The officers of the
Corporation shall be chosen by the Board of Directors and shall be a Chief Executive Officer, a President, one or more Vice
Presidents, a Secretary and a Treasurer. The Board of Directors may also choose one or more Assistant Secretaries and Assistant
Treasurers, and such other officers as it shall deem necessary. Any number of offices may be held by the same person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 63pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The salaries of all officers of the Corporation shall be fixed by the Board of Directors, or in such manner as the Board of Directors
may prescribe.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 63pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The officers of the Corporation shall hold office until their successors are elected and qualified, or until their earlier resignation
or removal. Any officer may be at any time removed from office by the Board of Directors, with or without cause. If the office of any
officer becomes vacant for any reason, the vacancy may be filled by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 63pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Any officer may resign at any time by giving <STRIKE STYLE="color: Red">written </STRIKE>notice of his or her resignation to the <STRIKE STYLE="color: Red">Board of
Directors. </STRIKE><U STYLE="color: rgb(50,101,255)">Corporation in writing or by electronic transmission. </U>Any such resignation shall take effect upon
receipt thereof by the <STRIKE STYLE="color: Red">Board of Directors</STRIKE><U STYLE="color: rgb(50,101,255)">Corporation</U> or at such later date as may be specified therein.<STRIKE STYLE="color: Red"> Any
such notice to the Board of Directors shall be addressed to it in care of the Secretary.</STRIKE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 63pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Chief Executive Officer shall have general supervision and direction of the business and affairs of the Corporation, subject,
however, to the direction and control of the Board of Directors. The Chief Executive Officer may sign and execute in the name of the Corporation
deeds, mortgages, bond, contracts or other instruments. The Chief Executive Officer shall perform all duties incident to the office of
the Chief Executive Officer and shall, when requested, counsel with and advise the other officers of the Corporation and shall perform
such other duties as the Board of Directors may from time to time determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">6.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The President shall have such powers and perform such duties as from time to time may be assigned to him by the Chief Executive
Officer or the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 63pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">7.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Vice Presidents shall have such powers and duties as may be delegated to them by the Chief Executive Officer or the Board of
Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">8.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Secretary <FONT STYLE="letter-spacing: -0.4pt"><U STYLE="color: rgb(50,101,255)">shall perform all duties incident to the office of the Secretary and</U></FONT>
shall have such powers and duties as may be delegated to him by the Chief Executive Officer or the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">9.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Assistant Secretary shall, in case of the absence of the Secretary, perform the duties and exercise the powers of the Secretary,
and shall have such other powers and duties as may be delegated to them by the Chief Executive Officer or the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">10.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Treasurer shall have the custody of the corporate funds and securities, and shall deposit or cause to be deposited under his
or her direction all moneys and other valuable effects in the name and to the credit of the Corporation in such depositories as may be
designated by the Board of Directors or pursuant to authority granted by it. He shall render to the Chief Executive Officer and the Board
of Directors whenever they may require it an account of all his or her transactions as Treasurer and of the financial condition of the
Corporation. He shall have such other powers and duties as may be delegated to him by the Chief Executive Officer or the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">11.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Assistant Treasurer shall, in case of the absence of the Treasurer, perform the duties and exercise the powers of the Treasurer,
and shall have such other powers and duties as may be delegated to them by the Chief Executive Officer or the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.5pt"><U STYLE="color: Green">ARTICLE</U></FONT><U STYLE="color: Green">
<FONT STYLE="letter-spacing: -0.45pt">X</FONT></U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.5pt"><STRIKE STYLE="color: Green">ARTICLE
XI</STRIKE></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.2pt">FORM
OF CERTIFICATES&#894; UNCERTIFICATED</FONT> <FONT STYLE="letter-spacing: -0.15pt">SHARES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.15pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">Shares of the capital stock of the Corporation may be certificated
or uncertificated, as provided under the General Corporation Law of the State of Delaware. Each stockholder <U STYLE="color: rgb(50,101,255)">holding certificated shares
of capital stock of the Corporation</U>, upon written request to the transfer agent or registrar of the Corporation, shall be entitled
to a certificate <STRIKE STYLE="color: Red">of the</STRIKE><FONT STYLE="letter-spacing: -0.3pt"><U STYLE="color: rgb(50,101,255)">representing such shares </U></FONT><U STYLE="color: rgb(50,101,255)">of</U> capital
stock of the Corporation in such form as may from time to time be prescribed by the Board of Directors. Any such certificate shall be
signed by <STRIKE STYLE="color: Red">the </STRIKE><FONT STYLE="letter-spacing: -0.25pt"><U STYLE="color: rgb(50,101,255)">any two authorized officers of the Corporation, which shall include,
without limitation, </U></FONT><U STYLE="color: rgb(50,101,255)">the </U>Chairman of the Board of Directors <STRIKE STYLE="color: Red">or</STRIKE><U STYLE="color: rgb(50,101,255)">, the Chief Executive Officer,</U>
the President <STRIKE STYLE="color: Red">or a</STRIKE><U STYLE="color: rgb(50,101,255)">, any</U> Vice President <STRIKE STYLE="color: Red">and by</STRIKE><U STYLE="color: rgb(50,101,255)">,</U> the Treasurer <STRIKE STYLE="color: Red">or an</STRIKE><U STYLE="color: rgb(50,101,255)">,
any</U> Assistant Treasurer <STRIKE STYLE="color: Red">or</STRIKE><U STYLE="color: rgb(50,101,255)">,</U> the Secretary <STRIKE STYLE="color: Red">or an</STRIKE><U STYLE="color: rgb(50,101,255)">and any</U> Assistant Secretary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.5pt"><U STYLE="color: Green">ARTICLE
XI</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.45pt"><STRIKE STYLE="color: Green">ARTICLE</STRIKE></FONT><STRIKE STYLE="color: Green">
<FONT STYLE="letter-spacing: -0.4pt">XII</FONT></STRIKE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><STRIKE STYLE="text-decoration: none; color: Red">&nbsp;</STRIKE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><STRIKE STYLE="color: Red">CHECKS</STRIKE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><STRIKE STYLE="text-decoration: none; color: Red">&nbsp;</STRIKE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><STRIKE STYLE="color: Red">All checks, drafts and other orders for the payment of money
and all promissory notes and other evidences of indebtedness of the Corporation shall be signed by such officer or officers or such other
person as may be designated by the Board of Directors or pursuant to authority granted by it.</STRIKE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><STRIKE STYLE="text-decoration: none; color: Red">&nbsp;</STRIKE></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.45pt"><STRIKE STYLE="color: Green">ARTICLE</STRIKE></FONT><STRIKE STYLE="color: Green">
<FONT STYLE="letter-spacing: -0.4pt">XIII</FONT></STRIKE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.25pt">FISCAL
</FONT><FONT STYLE="letter-spacing: -0.2pt">YEAR</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.2pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">The fiscal year of the Corporation shall be as determined from
time to time by resolution duly adopted by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.45pt"><U STYLE="color: Green">ARTICLE</U></FONT><U STYLE="color: Green">
<FONT STYLE="letter-spacing: -0.4pt">XII</FONT></U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.45pt"><STRIKE STYLE="color: Green">ARTICLE</STRIKE></FONT><STRIKE STYLE="color: Green">
<FONT STYLE="letter-spacing: -0.4pt">XIV</FONT></STRIKE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.15pt">NOTICES
AND WAIVERS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.15pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Whenever by statute, by the Certificate of Incorporation or by these By-laws it is provided that notice shall be given to any director,
such provision shall not be construed to require personal notice, but such notice may be given in writing, by mail, by depositing the
same in the United States mail, postage prepaid, directed to such director at his or her address as it appears on the records of the Corporation,
and such notice shall be deemed to be given at the time when the same shall be thus deposited. Notice of <STRIKE STYLE="color: Red">regular or special</STRIKE>
meetings of the Board of Directors may also be given to any director by telephone or by electronic transmission, and in the latter event
the notice shall be deemed to be given at the time such notice, addressed to such director at the address hereinabove provided, is transmitted
by facsimile <STRIKE STYLE="color: Red">or</STRIKE><U STYLE="color: rgb(50,101,255)">,</U> electronic mail <U STYLE="color: rgb(50,101,255)">or other electronic transmission</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Whenever by statute, by the Certificate of Incorporation or by these By-laws it is provided that notice shall be given to any stockholder,
such provision shall not be construed to require personal notice, but such notice may be given in writing, by mail, by depositing the
same in the United States mail, postage prepaid, directed to such stockholder at his or her mailing address as it appears on the records
of the Corporation, and such notice shall be deemed to be given at the time when the same shall be thus deposited. Such notice may also
be given <U STYLE="color: rgb(50,101,255)">(i) by courier service, and such notice shall be deemed to be given upon the earlier of when the notice is received or left
at the stockholder&rsquo;s address or (ii)</U> by electronic transmission directed to the stockholder&rsquo;s electronic mail address
as it appears on the records of the Corporation, and such notice shall be deemed to be given when directed to such stockholder&rsquo;s
electronic mail address unless the stockholder has notified the Corporation in writing or by electronic transmission of an objection to
receiving notice by electronic mail or such notice is prohibited by Section 232(e) of the General Corporation Law of the State of Delaware.
A notice by electronic mail will include a prominent legend that the communication is an important notice regarding the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Without limiting the manner by which notice otherwise may be given effectively to stockholders, any notice to stockholders given
by the Corporation under any provision of the General Corporation Law of the State of Delaware, the Certificate of Incorporation, or these
By-laws shall be effective if given by another form of electronic transmission consented to by the stockholder to whom the notice is given.
Any such consent shall be revocable by the stockholder by written notice or electronic transmission to the Corporation. Any such consent
shall be deemed revoked if (i) the Corporation is unable to deliver by electronic transmission two (2) consecutive notices given by the
Corporation in accordance with such consent and (ii) such inability becomes known to the Secretary or an Assistant Secretary or to the
transfer agent, or other person responsible for the giving of notice&#894; provided, however, the inadvertent failure to discover such
inability shall not invalidate any meeting or other action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">4.
Notice given pursuant to Section 3 of this Article <FONT STYLE="color: Red"><STRIKE>XIV</STRIKE></FONT><FONT STYLE="color: rgb(50,101,255)"><U>XII
</U></FONT>shall be deemed given: (i) if by facsimile telecommunication, when directed to a number at which the stockholder has consented
to receive notice&#894; (ii) if by a posting on an electronic network together with separate notice to the stockholder of such specific
posting, upon the later of (A) such posting and (B) the giving of such separate notice&#894; and (iii) if by any other form of electronic
transmission, when directed to the stockholder. An affidavit of the Secretary or an Assistant Secretary or of the transfer agent or other
agent of the Corporation that the notice has been given <FONT STYLE="color: Red"><STRIKE>by a form of electronic transmission </STRIKE></FONT>shall,
in the absence of fraud, be prima facie evidence of the facts stated therein. For purposes of this Article <FONT STYLE="color: Red"><STRIKE>XIV</STRIKE></FONT><FONT STYLE="color: rgb(50,101,255)"><U>XII</U></FONT>,
&ldquo;electronic transmission&rdquo; means any form of communication, not directly involving the physical transmission of paper, including
the use of, or participation in, 1 or more electronic networks or databases (including 1 or more distributed electronic networks or databases),
that creates a record that may be retained, retrieved and reviewed by a recipient thereof, and that may be directly reproduced in paper
form by such a recipient through an automated process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Whenever by statute, by the Certificate of Incorporation or by these By-laws a notice is required to be given, a written waiver
thereof, signed by the person entitled to notice, or a waiver by electronic transmission by the person entitled to notice, whether before
or after the time stated therein, shall be deemed equivalent to notice. Attendance of any stockholder or director at any meeting thereof
shall constitute a waiver of notice of such meeting by such stockholder or director, as the case may be, except as otherwise provided
by statute.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.45pt"><U STYLE="color: Green">ARTICLE</U></FONT><U STYLE="color: Green">
<FONT STYLE="letter-spacing: -0.4pt">XIII</FONT></U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.45pt"><STRIKE STYLE="color: Green">ARTICLE
XV</STRIKE></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">INDEMNIFICATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Corporation shall indemnify to the maximum extent permitted by law any person who was or is a party or is threatened to be
made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative
(other than an action by or in the right of the corporation) by reason of the fact that such person is or was a director or officer of
the Corporation, or is or was serving at the request of the Corporation as a director or officer of another corporation, partnership,
joint venture, trust or other enterprise, against expenses (including attorneys&rsquo; fees), judgments, fines and amounts paid in settlement
actually and reasonably incurred by such person in connection with such action, suit or proceeding if such person acted in good faith
and in a manner such person reasonably believed to be in or not opposed to the best interests of the Corporation, and, with respect to
any criminal action or proceeding, had no reasonable cause to believe such person&rsquo;s conduct was unlawful. The termination of any
action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not,
of itself, create a presumption that the person did not act in good faith and in a manner which such person reasonably believed to be
in or not opposed to the best interests of the Corporation, and, with respect to any criminal action or proceeding, had reasonable cause
to believe that such person&rsquo;s conduct was unlawful. <U STYLE="color: rgb(50,101,255)">Notwithstanding the provisions of this Section 1, except as otherwise provided
in Section 4 of this Article XIII, the Corporation shall be required to indemnify any person referenced in this Section 1 in connection
with an action, suit or proceeding (or part thereof) commenced by such person only if the commencement of such action, suit or proceeding
(or part thereof) by the person was authorized in the specific case by the Board of Directors.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Corporation shall indemnify to the maximum extent permitted by law any person who was or is a party or is threatened to be
made a party to any threatened, pending or completed action or suit by or in the right of the Corporation to procure a judgment in its
favor by reason of the fact that such person is or was a director or officer of the corporation, or is or was serving at the request of
the Corporation as a director or officer of another corporation, partnership, joint venture, trust or other enterprise against expenses
(including attorneys&rsquo; fees) actually and reasonably incurred by such person in connection with the defense or settlement of such
action or suit if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best
interests of the Corporation and except that no such indemnification shall be made in respect of any claim, issue or matter as to which
such person shall have been adjudged to be liable to the Corporation unless and only to the extent that the Court of Chancery of the State
of Delaware (the &ldquo;Court of Chancery&rdquo;) or the court in which such action or suit was brought shall determine upon application
that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled
to indemnity for such expenses which such Court of Chancery or such other court shall deem proper.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Expenses (including attorneys&rsquo; fees) incurred by <STRIKE STYLE="color: Red">an</STRIKE><U STYLE="color: rgb(50,101,255)">a present or former</U> officer or director in defending
any civil, criminal, administrative or investigative action, suit or proceeding <STRIKE STYLE="color: Red">may</STRIKE><U STYLE="color: rgb(50,101,255)">shall</U> be paid by the Corporation
in advance of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of such director
or officer to repay such amount if it shall ultimately be determined that such person is not entitled to be indemnified by the Corporation
as authorized in this Article <STRIKE STYLE="color: Red">XV. </STRIKE><U STYLE="color: rgb(50,101,255)">XIII. </U>Such expenses (including attorneys&rsquo; fees) incurred by
<STRIKE STYLE="color: Red">former directors</STRIKE><U STYLE="color: rgb(50,101,255)">employees</U> and <STRIKE STYLE="color: Red">officers</STRIKE><U STYLE="color: rgb(50,101,255)">agents</U> may be so paid upon such terms and conditions,
if any, as the Corporation deems appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">4. The indemnification
and advancement of expenses provided by, or granted pursuant to, the other Sections of this Article <FONT STYLE="color: Red"><STRIKE>XV</STRIKE></FONT><FONT STYLE="color: rgb(50,101,255)"><U>XIII </U></FONT>shall
not be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under
any <FONT STYLE="color: Red"><STRIKE>Bylaw</STRIKE></FONT><FONT STYLE="color: rgb(50,101,255)"><U>By-law</U></FONT>, agreement, vote
of stockholders or disinterested directors or otherwise, both as to action in such person&rsquo;s official capacity and as to action
in another capacity while holding such office.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Corporation may, but shall not be required to, purchase and maintain insurance on behalf of any person who is or was a director
<STRIKE STYLE="color: Red">or</STRIKE><U STYLE="color: rgb(50,101,255)">,</U> officer<U STYLE="color: rgb(50,101,255)">, employee or agent</U> of the Corporation, or is or was serving at the request of the Corporation
as a director <STRIKE STYLE="color: Red">or</STRIKE><U STYLE="color: rgb(50,101,255)">,</U> officer<U STYLE="color: rgb(50,101,255)">, employee or agent</U> of another corporation, partnership, joint venture, trust
or other enterprise against any liability asserted against such person and incurred by such person in any such capacity, or arising out
of such person&rsquo;s status as such, whether or not the <STRIKE STYLE="color: Red">corporation</STRIKE><U STYLE="color: rgb(50,101,255)">Corporation</U> would have the power to indemnify
such person against such liability under the provisions of this Article <STRIKE STYLE="color: Red">XV</STRIKE><U STYLE="color: rgb(50,101,255)">XIII</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">6.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>For purposes of this Article <STRIKE STYLE="color: Red">XV</STRIKE><U STYLE="color: rgb(50,101,255)">XIII</U>, references to &ldquo;the Corporation&rdquo; shall include, in addition
to the resulting corporation, any constituent corporation (including any constituent of a constituent) absorbed in a consolidation or
merger which, if its separate existence had continued, would have had power and authority to indemnify its directors or officers so that
any person who is or was a director or officer of such constituent corporation, or is or was serving at the request of such constituent
corporation as a director or officer of another corporation, partnership, joint venture, trust or other enterprise, shall stand in the
same position under the provisions of this Article <STRIKE STYLE="color: Red">XV</STRIKE><U STYLE="color: rgb(50,101,255)">XIII</U> with respect to the resulting or surviving corporation
as such person would have with respect to such constituent corporation if its separate existence had continued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 60.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">7.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>For purposes of this Article <STRIKE STYLE="color: Red">XV</STRIKE><U STYLE="color: rgb(50,101,255)">XIII</U>, references to &ldquo;other enterprises&rdquo; shall include employee
benefit plans&#894; references to &ldquo;fines&rdquo; shall include any excise taxes assessed on a person with respect to an employee
benefit plan&#894; and references to &ldquo;serving at the request of the Corporation&rdquo; shall include service as a director or officer
of the Corporation which imposes duties on, or involves services by, such director or officer with respect to an employee benefit plan,
its participants or beneficiaries&#894; and a person who acted in good faith and in a manner such person reasonably believed to be in
the interest of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner &ldquo;not opposed
to the best interests of the Corporation&rdquo; as referred to in this Article <STRIKE STYLE="color: Red">XV</STRIKE><U STYLE="color: rgb(50,101,255)">XIII</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">8.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The indemnification and advancement of expenses provided by, or granted pursuant to, this Article <STRIKE STYLE="color: Red">XV</STRIKE><U STYLE="color: rgb(50,101,255)">XIII</U>
shall, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a director or officer and shall
inure to the benefit of the heirs, executors and administrators of such a person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">9.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>If this Article or any portion hereof shall be invalidated on any ground by any court of competent jurisdiction, then the Corporation
shall nevertheless indemnify each director or officer to the fullest extent not prohibited by any applicable portion of this Article that
shall not have been invalidated, or by any other applicable law. If this Article shall be invalid due to the application of the indemnification
provisions of another jurisdiction, then the Corporation shall indemnify each director and officer to the fullest extent under any other
applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">10.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Corporation may indemnify every person who was or is a party or is or was threatened to be made a party to any action, suit,
or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he is or was an employee or agent
of the corporation or, while an employee or agent of the Corporation, is or was serving at the request of the corporation as an employee
or agent or trustee of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, against expenses
(including counsel fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him in connection with such
action, suit or proceeding, to the extent permitted by Delaware law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><STRIKE STYLE="text-decoration: none; color: Red">&nbsp;</STRIKE></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><STRIKE STYLE="color: Red">ARTICLE XVI</STRIKE></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><STRIKE STYLE="text-decoration: none; color: Red">&nbsp;</STRIKE></B></P>

<P STYLE="color: rgb(47,100,255); font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><U>11.
<FONT STYLE="color: rgb(50,101,255)">The Corporation&rsquo;s obligation, if any, to indemnify or to advance expenses to any person serving
at its request as a director or officer of another corporation, partnership, joint venture, trust or other enterprise shall be reduced
by any amount such person may collect as indemnification or advancement of expenses from such other corporation, partnership, joint venture,
trust or other enterprise.</FONT></U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><U STYLE="text-decoration: none; color: rgb(50,101,255)">&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><U STYLE="color: rgb(50,101,255)"></U></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><U STYLE="text-decoration: none; color: rgb(50,101,255)">&nbsp;</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.45pt"><U STYLE="color: Green">ARTICLE</U></FONT><U STYLE="color: Green">
<FONT STYLE="letter-spacing: -0.4pt">XIV</FONT></U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.25pt">FORUM</FONT>
<FONT STYLE="letter-spacing: -0.2pt">SELECTION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.2pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT> Unless the Corporation consents in writing to the selection of an alternative forum, the Court of Chancery (or, if and only if
the Court of Chancery lacks subject matter jurisdiction, any state or federal court located within the State of Delaware) and any appellate
court thereof shall be the sole and exclusive forum for (i) any derivative action, suit, or proceeding brought on behalf of the Corporation,
(ii) any action, suit, or proceeding asserting a claim of breach of fiduciary duty owed by any current or former director, officer, employee,
or stockholder of the Corporation to the Corporation or the Corporation&rsquo;s stockholders or any action asserting a claim for aiding
and abetting any such breach of fiduciary duty, (iii) any action, suit, or proceeding arising pursuant to any provision of the General
Corporation Law of the State of Delaware or the Certificate of Incorporation or these By-laws (as each may be amended from time to time),
(iv) any claim as to which the General Corporation Law of the State of Delaware confers jurisdiction upon the Court of Chancery, or (v)
any action, suit, or proceeding asserting a claim against the Corporation or its current or former directors, officers, employees, or
stockholders governed by the internal affairs doctrine, in each such case subject to such court having personal jurisdiction over the
indispensable parties named as defendants therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Unless the Corporation consents in writing to the selection of an alternative forum, to the fullest extent permitted by law, the
federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause
of action arising under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Notwithstanding the foregoing, the provisions of this Article <STRIKE STYLE="color: Red">XVI</STRIKE><U STYLE="color: rgb(50,101,255)">XIV</U> shall not apply to suits brought to
enforce any liability or duty created by the Securities Exchange Act of 1934, as amended, or any other claim for which the federal courts
of the United States have exclusive jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Any person or entity purchasing or otherwise acquiring any interest in shares of capital stock of the Corporation shall be deemed
to have notice of the provisions of this Article <STRIKE STYLE="color: Red">XVI</STRIKE><U STYLE="color: rgb(50,101,255)">XIV</U>. If any provision or provisions of this Article <STRIKE STYLE="color: Red">XVI</STRIKE><U STYLE="color: rgb(50,101,255)">XIV</U>
shall be held to be invalid, illegal or unenforceable as applied to any person or entity or circumstance for any reason whatsoever, then,
to the fullest extent permitted by law, the validity, legality and enforceability of such provisions in any other circumstance and of
the remaining provisions of this Article <STRIKE STYLE="color: Red">XVI</STRIKE><U STYLE="color: rgb(50,101,255)">XIV</U> (including, without limitation, each portion of any sentence of
this Article <STRIKE STYLE="color: Red">XVI</STRIKE><U STYLE="color: rgb(50,101,255)">XIV</U> containing any such provision held to be invalid, illegal or unenforceable that is not itself
held to be invalid, illegal or unenforceable) and the application of such provision to other persons or entities and circumstances shall
not in any way be affected or impaired thereby.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.45pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="letter-spacing: -0.45pt"><U STYLE="color: Green">ARTICLE
XV</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><STRIKE STYLE="color: Red">ARTICLE XVII</STRIKE></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><STRIKE STYLE="text-decoration: none; color: Red">&nbsp;</STRIKE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><STRIKE STYLE="color: Red">ALTERATION</STRIKE><FONT STYLE="letter-spacing: -0.3pt"><U STYLE="color: rgb(50,101,255)">AMENDMENT</U></FONT>
<FONT STYLE="letter-spacing: -0.25pt">OF BY-LAWS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The By-laws of the Corporation may be altered, amended or repealed,
and new By-laws may be adopted, by the <STRIKE STYLE="color: Red">stockholders or by the Board of Directors</STRIKE><U STYLE="color: rgb(50,101,255)">Board of Directors. In addition, the
By-laws of the Corporation may be altered, amended or repealed, and new By-laws may be adopted, by the stockholders of the Corporation
by the affirmative vote of the holders of a majority in voting power of the outstanding shares of capital stock of the Corporation entitled
to vote thereon</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">17</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>ormp-20230223.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kk5s7xRiXhun8uNbHcsWaOFCaPtzp952YlBuGlzfVk6zyEhhWwrWiBoS9DGIcgK -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:ORMP="http://oramed.com/20230223" elementFormDefault="qualified" targetNamespace="http://oramed.com/20230223">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://oramed.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="ormp-20230223_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ormp-20230223_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>ormp-20230223_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>ormp-20230223_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://oramed.com/role/Cover" xlink:href="ormp-20230223.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://oramed.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139630538469888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 23, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 23,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35813<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ORAMED PHARMACEUTICALS INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001176309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-0376008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1185 Avenue of the Americas<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Third Floor<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">844<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">967-2633<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ORMP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>ea174308-8k_oramed_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ormp-20230223.xsd" xlink:type="simple"/>
    <context id="From2023-02-23to2023-02-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001176309</identifier>
        </entity>
        <period>
            <startDate>2023-02-23</startDate>
            <endDate>2023-02-23</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-02-23to2023-02-23">0001176309</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-02-23to2023-02-23">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2023-02-23to2023-02-23">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="From2023-02-23to2023-02-23">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-02-23to2023-02-23">2023-02-23</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-02-23to2023-02-23">ORAMED PHARMACEUTICALS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-02-23to2023-02-23">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-02-23to2023-02-23">001-35813</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-02-23to2023-02-23">98-0376008</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-02-23to2023-02-23">1185 Avenue of the Americas</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-02-23to2023-02-23">Third Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-02-23to2023-02-23">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-02-23to2023-02-23">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-02-23to2023-02-23">10036</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-02-23to2023-02-23">844</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-02-23to2023-02-23">967-2633</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-02-23to2023-02-23">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-02-23to2023-02-23">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-02-23to2023-02-23">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-02-23to2023-02-23">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-02-23to2023-02-23">Common Stock, par value $0.012</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-02-23to2023-02-23">ORMP</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-02-23to2023-02-23">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-02-23to2023-02-23">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MRMN"\O82RB'LJ(+=',<!?R=?^4<5)ZYD0_)HI^W:MP@6M4O3M"\!6[!W,@Z
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MY?.J>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^
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M$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ LHA;5@=!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M" "RB%M60>G1W^X    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    " "RB%M6F5R<(Q &  "<)P  $P
M    @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( +*(6U;'
ME=/^A00  +\1   8              " @0T(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    " "RB%M6GZ ;\+$"  #B#   #0
M    @ '(#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( +*(6U:7BKL<P
M !,"   +              "  :0/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M +*(6U:JQ"(6,P$  "("   /              "  8T0  !X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    " "RB%M6)!Z;HJT   #X 0  &@
M@ 'M$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "R
MB%M699!YDAD!  #/ P  $P              @ '2$@  6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     "0 ) #X"   <%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea174308-8k_oramed.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://oramed.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ea174308-8k_oramed.htm">ea174308-8k_oramed.htm</File>
    <File>ea174308ex3-1_oramed.htm</File>
    <File>ea174308ex3-2_oramed.htm</File>
    <File>ormp-20230223.xsd</File>
    <File>ormp-20230223_lab.xml</File>
    <File>ormp-20230223_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ea174308-8k_oramed.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 24
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "ea174308-8k_oramed.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ormp-20230223_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ormp-20230223_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ormp-20230223.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ORMP",
   "nsuri": "http://oramed.com/20230223",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea174308-8k_oramed.htm",
      "contextRef": "From2023-02-23to2023-02-23",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://oramed.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea174308-8k_oramed.htm",
      "contextRef": "From2023-02-23to2023-02-23",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://oramed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001213900-23-014884-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-23-014884-xbrl.zip
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M)?,PW@4.;"0K;6'9R?&MOW-S^5C9ZTNGR]C6FL:9*F)0 \FV7%-]V"(6M<F
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MBMU$78-_!;5AAH5Z6%_K4XUAW[ 3RELHD E=AAL62+4O] "J:>BC,+>+[6H
M:K_?!,@3)'S4<WNF#;%="_5^A'I''@>;ZVO A*<R_S3/Y- /T!-R-D+RJ3;
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MQ!Z .75Y-C-/X8?+2YS](L\JVN\F7]0=\KS%8E454]TYT &FP =G605[>U&
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M<%7[S $G\[EF0.E&5A_]',?N7YT>:USGG=N9?)#$,HI0%[@%]KV!O79B/*1
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M!Q!*J_+WZ7!15#&]S?*Y>K;5L?2]EZE@ ,O6S<2M]/1N__[!$[W.6Z^+3_U
MM\-*%7[OTF9#\D(3=YW1V9H#*EK9J44V,P0<5O4A-Z/[P2(?KYE 82W$+0AB
MMD.:UP_V/!&I!OUC,U2#%^/<[.C&Y Z0%&[&)UYXD#JYQ+U4.-LGQL8BE P'
M+O >SKW)6I-0 V-.0(MAEGA+'L$G=Q:UM?+Y9@+:R.?"M41]8;UVQYE^YJN&
MF#3")"]GF4(\6I<.LD"XQ@:B/$7V&*^1-6Z(NO$2+"8^ E#; V0@*+850S"
MYHBZK51*4V:42:KO^QM<PUXOE@2LX#:9E&7#VOI7W;*KC7?)^()XAV!FO&7!
MCCFP,CO3?:Y7ZV'9/>T))O["\_LOP@VQL8MU>[P? #;@S_$-" Z?V%G6.CD:
MYB-C&P-PQ%).,&_[WZT]N-@<:8\+WTM))4**%>@<Z2REG%TKGY8-^DHX.N&D
MPV])%3?;'H8^G-\2Q8[O/R^]$3.UMLZ@QLB&:M&RMA1#GLIL;ES?2$JI<(
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MN-^!$7\MV&^25E?%_4YV!/N--8!7QOU.=@?[/=J['NYW<G/8;V2&-\3]3FX
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M9JF-7# 7]0H]$;E_ER;YU0S07?6=ZMF?% 3Q#5 U.^$C9B-< ]1:FM<P,S?
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M&.@@O_[BGOIOM_?4;W:;!P<2D,(__OGVU7]^QA]^/?GM]<__'U!+ P04
M" "RB%M6$L$=P]Y9  "O1P( &    &5A,3<T,S X97@S+3)?;W)A;65D+FAT
M;>U]67/;6-+ENR+T'S ],3UB!*RRO-0^%:&RY2Y%N^P*6W9W/X(D**(, FP
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MT^;ZVFU_SS\<UE9IJ$-S6D+WN/3&G9?+/%&-&&5DZ8)<RM&[!.,#AP8#D$
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MY"5P+@LX(XS]I(VVRS48 ?20X=]^AO_)3\';):7K?L31B9S_%'R,TA7^^:X
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M[P??^]QLQ;W!I(G1\0NZV_YU>O;;VP]GP7$@C][E((??.>:O&.5X)]?"@+M
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M]PD;-:W[/OS6;W4Z%C@[_?01Z%_C,X2@33#UZ^"">[##AOP$W* IKH-+S+!
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M]$)XEC!Z/CH^^CA"A$8L3NCZ?/1U,;Y8S.;S$<IR3&.<,DK.1Y2-?OSACW]
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MG-Z39\:[\&G*7%-C,VG"4M<$Q8C%&(B&TB(E]D3$/[;BC)WP=-\+14OIF@O
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M+T/U"M!*/B-65H%^DY6@HA;;[Y?7-UV+3V*SWB3^6N&,B"W_!5!+ P04
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M_,VEMG_!FP;!<M#08"[B!!A'N@K2/Q9ZT>1Z_4"G5+EI"H]T9:YM0T_ABR)
M<6A\4-\H!,90$::+SI&O6[O!O9NV^,;]<N]?M5O^!U!+ 0(4 Q0    ( +*(
M6U:V-YU*A10  *%R   6              "  0    !E83$W-#,P."TX:U]O
M<F%M960N:'1M4$L! A0#%     @ LHA;5D1%[\^'3@  E.D! !@
M     ( !N10  &5A,3<T,S X97@S+3%?;W)A;65D+FAT;5!+ 0(4 Q0    (
M +*(6U82P1W#WED  *]' @ 8              "  79C  !E83$W-#,P.&5X
M,RTR7V]R86UE9"YH=&U02P$"% ,4    " "RB%M6>F$A'% #  "S#   $0
M            @ &*O0  ;W)M<"TR,#(S,#(R,RYX<V102P$"% ,4    " "R
MB%M6HIOKK/X*  " A@  %0              @ $)P0  ;W)M<"TR,#(S,#(R
M,U]L86(N>&UL4$L! A0#%     @ LHA;5A()HZU6!P  T5<  !4
M     ( !.LP  &]R;7 M,C R,S R,C-?<')E+GAM;%!+!08     !@ & )4!
(  ##TP     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
